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Abstract 
          Low molecular weight gelators (LMWGs) have gained great attention over the past two 
decades. These compounds form self-assembled fibrous networks like micelles, cylindrical, 
sheets, fibers, layers and so on. The fibrous network entraps the solvent and form gel.  LMWGs 
are interesting compounds with many potential applications in material and biomedical sciences.  
         Many different structures have been found to be good LMWGs. Our interests focus on the 
carbohydrate based LMWGs. Previously, we have found that several ester derivatives of 4, 6-O-
benzylidene-α-methyl-D-glucopyranoside are good gelators for organic solvents and aqueous 
solutions. In this study, in order to understand the structure requirement, we systematically 
investigated the influence of sugar head groups and the attached hydrophobic tails towards 
gelation. First we investigated different anomeric position functional groups in compound 1, 2. 
And then functional group at 4, 6 positions are studied in compound 3. 
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                 The D-glucosamine derivatives are also studied with different functional groups at 4, 6 
positions in compounds 4, 5, 6, and 7.  
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The design, synthesis and gelation properties of esters, amides, ureas, carbamates derived from 
sugar head groups shown above will be discussed in chapter II, III, IV.  
 
Keywords: low molecular weight gelator, monosaccharide, glucosamine.  
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                                                     Chapter I 
                                                   Introduction 
Abstract: Low Molecular Weight Gelators (LMWGs) usually refer to small molecules with 
molecular weight lower than 3000. The gels formed by LMWGs are usually thermally reversible. 
The mechanism of gelation by Low Molecular Weight Gelators is still not very clear. Generally, 
hydrogen bonds are required to enforce the one-dimensional structure. The molecular 
architecture of two-dimensional and three-dimensional structures is the results of π-π interaction, 
hydrophobic interactions, Van der Waals forces.  In the gel structure, the interactions between 
gel molecules and solvent molecules are very critical. The energy between these two will 
determine whether it will form gel. To study the interaction and gel structures, different 
techniques like small angle X-ray scattering (SAXS), transmission electronic microscope (TEM), 
scanning electronic microscope (SEM), infra-red (IR), circular dichroism (CD), nuclear magnetic 
resonance (NMR) and so on, have been employed. The applications of LMWGs are very 
promising, including but not limited to DNA purification, drug delivery, enzyme immobilization, 
tissue engineering, controlled release of biological agents, liquid crystalline materials, 
biosensing, and environment remediation. In this chapter, all above mentioned aspects of 
LMWGs will be briefly reviewed. 
 
 
Keywords: self-assembly, Low Molecular Weight Gelator, gelation.  
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1.1 General Introduction of Gel 
             Gel is widely used in cosmetic products, lubricants, medicines and food processing. A 
gel is mostly liquid which is trapped in a three dimensionally cross-linked structure. Different 
materials are found to be gelators. By molecular weight, gelators can be divided into polymers 
and low molecular weight gelators (LMWGs).
1-7
 Most of gels that we see in our daily life are 
formed by polymers. The internal cross-linked structures of polymer gels are formed by covalant 
bonds. Some examples are shown in Figure 1.1.
8,9
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1 2  
                                                   Figure 1.1 Examples of polymer gelators 
 
                Because of strong chemical bonds, polymer gels are stable and typically thermally 
irreversible. They also have a distribution of molecular weight. However, for LMWGs, the cross-
linked structures of a gel are formed by non-covalent bonds. These include hydrogen bonds, Van 
der Waals forces, hydrophobic interactions, π-π interactions and so on.10-12 Some examples are 
shown in Figure 1.2.
13-15
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X *
X= COO,  n=15
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                           Figure 1.2 Examples of LMWGs based on steroid and pyrene  
                                                                 
            In comparison with polymer gel, the mechanism of gel formation by LMWGs is also 
different. What is now accepted by most researchers is the three steps gelation process.
 16-19
  
First, gelator molecules are aggregated in one dimension by multiple non-covalent interactions 
like hydrogen bond. Second, micelles, vesicles, fibers, ribbons or sheets are formed. Third, 
interactions between fibers or sheets lead to network which trap solvent molecules and form the 
final gel. Because physical bonds are not as stable as chemical bonds, the gels are thermally 
reversible.  
 
           By different gel solvents, gelators can be divided into hydrogelators and organogelators. 
The driving forces of gels formed by hydrogelators are hydrophobic force. There are examples 
from both polymers and low molecular weight gelators.
20,21
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                                                    Figure 1.3 Examples of hydrogelators 
 
              Because the resulting gels’ aqueous environment, hydrogelators are very useful in 
application for human health. Hydrogels are currently used as scaffolds to contain human cells to 
repair tissue.
22 
Electroencephalography and electrocardiography use hydrogel as electrodes.
23
 
Contact lenses are made of silicone hydrogels, polyacrylamide.
24,25
 Organogelators depend on 
hydrogen bonds, Van der Waals forces and other non-covalent forces to form gel in organic 
solvents.
26-29 
 
           If the liquid is removed from the gel’s cross-linked networks, the resulting structure will 
have extremely low density and thermal conductivity. Different drying processes produce 
aerogel and xerogel. An aerogel is made by supercritical drying, and a xerogel is made by 
unhindered shrinkage.
30, 31
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1.2 Gel Preparation 
 The gel formation process can be triggered by different factors. Temperature change is 
one of the most common ways to make a gel. Typically, a 2-3 mg sample is weighed and 
transferred into a small vial, the test solvent was added. The sample is usually dissolved by 
heating and left at room temperature for gelation to happen.
32,33
 The limitation of using heat in 
biological application is obvious, so different methods are developed.
34 
 These are discussed in 
the following.  
 
        Changing solution pH is usually carried out by adding a diluted acid/base, or adding 
another reagent which can cause hydrolysis of the compound in the solution.
35,36
 For example, 
through the neutralization of aqueous alkaline solution of scleroglucan, the scleroglucan gel 
formed in situ with a structure of cross-linking of the polysaccharide
.37
 In this case, formamide or 
ethyl acetate was added.  
 
        Adding another reagent usually triggers a reaction which yields the compound that can 
form gel in test solvents.
38
 This usually refers to as in situ gelation. The following reaction was 
carried out in a DMSO and water mixture.
39
 Two equiv ceric ammonium nitrate (CAN) was used 
and after the reaction is completed, a gel formed in a 2 to 1 ratio DMSO and water mixture.  
6 
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                                    Figure 1.4 Examples of gelation triggered by a reaction. 
 
             Triggered mechanisms are not limited to oxidation or reduction reactions. Ligand-
receptor interaction, enzyme reactions in biological system can also be used to introduce 
gelation. In a recent paper,
40
  thermolysin was used in a solution of the short tetrapeptide FEFK. 
In the solution, hydrolysis of thermolysin happened and after certain amount of time the 
equilibrium was reached. At the same time, the short peptides self-assembled into antiparallel β-
sheet which further assembled into fibers and then led to gelation. Bing Xu’s group use a 
kinase/phosphatase switch to control a supermolecular hydrogel.
41
 In the presence of adenosine 
triphosphates (ATP), hydrogelator Nap-FFGEY is treated with kinase, which leads to a gel-sol 
phase transition.  
 
  Light can also be used to trigger gelation.
42,43 
One example is the photocaged peptide 
VKVKVKVKV
D
PPTKVKXKVKV-NH2.
44 
The X structure is shown in Figure 1.5.  The 2 wt % 
solution of this peptide in water was very stable under the ambient light. But when the solution 
was treated with (260 < λ < 360 nm) light, the peptide begin to fold and produce amphiphilic α-
hairpins which further assemble into fibers and lead to the gelation.  
7 
 
 
 
                                                               
NO2
CO2
S
N
H O
X=
9  
                          Figure 1.5 The structure of compound 9 in the photocaged peptide 
 
       Magnetic field is another factor that can change the gel performance.
 
The engineers at 
Harvard and Duke Universities were able to make a magnetic field controlled gel sponge.
45
 The 
macroporous ferrogel was mixed with magnetic iron nanoparticles. When a magnetic field is 
applied, the gel can be compressed to as much as 70%. Laura J. Kaufman from Columbia 
University used surface-modified magnetic beads in collagen solution to align thin collagen 
gels.
46
 Their research showed when the magnetic beads were coated with streptavidin lead 
(metal), the alignment is the best.    
 
       Ultrasound has also been used for the formation of gels. A recent example used this 
method.
47
 The compound 10 forms a gel in N, N-dimethylformamide (DMF) with the sonication 
treatment. The gelation concentration is 0.85% in DMF. The sonication source is an ultrasonic 
cleaner (0.45W/cm
2
, 40kHz, 30s).     
8 
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10    
                                    Figure 1.6 An example of ultrasound triggered gelator 
 
         Besides these mentioned methods, there are also other methods like electric field,
48
 adding 
metal ion
49, 50
 and multiple stimuli.
51 
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1.3 Low Molecular Weight Gelators (LMWGs). 
           LMWGs have gained people’s attention for the last two decades. Even though the design 
of LMWGs is sometimes depending on luck, researchers are able to find gelators from different 
classes of compounds including but not limited to acids, ureas, amides, carbamates, esters, 
carbohydrate, steroids, nucleotides, nucleosides, amino acids, alcohol etc. Some examples are 
shown in Figure 1.7.
52-73 
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Figure 1.7 Examples of LMWGs from different classes. Amide gelator, urea gelator, steroid 
based gelator, ester gelator, alcohol gelator, nucleotide gelator, nucleoside gelator. 
10 
 
 
           With the help of modern instruments like small angle X-ray scattering (SAXS), circular 
dichroism (CD), solid phase nuclear magnetic resonance (NMR), differential scanning 
calorimetry (DSC), the understanding of gelation mechanisms and gelation structure relationship 
of LMWGs are significantly improved. The design of LMWGs usually requires balance of 
polarity, hydrophobic interaction and functional groups that can interact with solvent 
molecules.
74,75
  
 
1.3.1 Carbohydrate based Low molecular weight gelator 
            Being different from some expensive materials, carbohydrate is natural and inexpensive.  
The abundance and availability of carbohydrate are not the only reasons, structures of 
carbohydrate also give people different functional groups to play with. Carbohydrate has several 
hydroxyl groups which are available for introducing other functional groups like urea, amide, 
carbamate. The hydroxyl groups are very good hydrogen bonding donor, which will be very 
useful in gel formation. 
 
                                                  Figure 1.8 The structures of typical sugars 
11 
 
          The study of carbohydrate as gelator started about several decades ago. Different 
approaches were taken to modify carbohydrate structures. Carbohydrate polymer was explored 
first.     
 
         Carbohydrate polymer is one of many naturally occurring polymers.  Starches consist of 
amylose which is made by chain polymers of α-D-glucose and amylopectin is a branched 
structure of glucose polymer. Cellulose is a glucose polymer linked by beta-linkage. Bacterial 
cell wall is mainly composed of polysaccharides. To make carbohydrate polymer to function as a 
gelator usually requires structure modification of the polymer or attach another component to the 
polymer.  
 
          Mazzei Franco’s research group synthesized a hydrogel using polysaccharide scleroglucan 
and borax (sodium borate) as cross-linking agent.
76,77
 The hydrogel was used in immobilization 
of redox protein on electrodes materials to study electron transfer mechanisms related with redox 
biomolecules. Unlike chemical cross-linking agents hydrogel can provide gentle environment for 
biomolecules. The porous structure also facilitates exchange of aqueous solution.  
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                                                    Figure 1.9 Repeating unit of scleroglucan 
 
          Scleroglucan has a triple helix conformation and it is very stable even at 90°C and up to 
pH=12. In their preparation, 20 μL of Scleroglucan (Sclg) hydrogel solution (1% w/v) was mixed 
with 14 μL of 0.015M borax solution (Sclg/borax equivalent ratio=1:1) and then test protein was 
added to achieve a final concentration of 2.5x10
-5 
M. The pyrolytic graphite electrode was 
covered by the solution and dried at room temperature. Three heme proteins (hemoglobin, 
myoglobin, horseradish peroxidase) were tested. The study of direct electrochemistry showed the 
peaks corresponding to the electron transfer between protein and electrode. The study also 
revealed that only the inner layer of hydrogel on the surface of electrode are responsible for 
electron transfer, which contribute to the showed redox peaks. Hydrogen peroxide was used to 
test biocatalytical property, results confirmed that protein in the hydrogel maintain biological 
activity. 
 
          The development of carbohydrate based LMWGs are later than carbohydrate based 
polymers. At the early period, glucose, mannose, galactose, glucosamine and small function 
13 
 
groups were studied. In 1998, Seiji Shinkai group from Kyushu University protected 
monosaccharides (D-glucose, D-galactose and D-mannose) at 4, 6 positions using benzaldehyde 
and ZnCl2. The reaction is more like a protection of hydroxyl groups.
78-80
 The products are 
shown in Figure 1.10. 
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                               Figure 1.10 The products of 4, 6 position protected sugars 
         Compound 21 was a good gelator (gelation concentration is 1.0 wt %) in different organic 
solvents like cyclohexane, benzene, toluene, p-xylene, CCl4, CS2. Compound 22 formed gel in 
the long chain alkanes like n-hexane, n-heptane, n-octane. Later, Seiji Shinkai’s group screened 
more α-sugar structures and explored β-sugars. The β-sugars are shown in Figure 1.11.   
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                                                    Figure 1.11 Structures of β sugar derivatives 
14 
 
            Thirty four solvents were tested in gelation properties. Compound 25 derived from β-
mannose behaved best and it formed gel in twelve solvents. Compound 23 derived from α-
mannose was the second and it gelled 10 solvents.  
 
         To understand the interaction between gelator molecules, Seiji Shinka’s group obtained 
gelators’ X-ray crystal structures.81  The arrows represent hydrogen bonds. 
               
O
O
HO
OH
O
OCH3
OO
O
O
O
O
H
H
21
O O
O
O
O
O
H
H
OO
O
O
O
O
H
H
O O
O
O
O
O
H
H
              
              Figure 1.12 Illustration of hydrogen bonds in the crystal structure of compound 21 
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         As we mentioned above the first step of gelation is usually the formation of hydrogen bond 
or other intermolecular interaction between gelator molecules. The X-ray crystal structure proved 
that there were two hydrogen bonding sites in the structure locating at 2-OH and 3-OH. Judging 
from the gel tests results, compound 21 is a good gelator in six solvents like benzene, toluene, p-
xylene and so on.  
 
           Compound 28 also have two hydrogen bond donors, but there is only one used for 
intermolecular connection. The other one is used for intramolecular interaction between 3-OH 
and 1-OMe. The crystal structure is shown in Figure 1.13. In comparison with compound 21, 28 
is not a good gelator at all. It didn’t form gel in any test solvent.  
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                                Figure 1.13 The illustration of hydrogen bonds in compound 28   
16 
 
       
          The Figure 1.14, 1.15 show the crystal structures of compound 29 and 30. As we can see, 
for compound 29, there is only a two dimensional layer and no one-dimensional array. 
Compound 30 did not have any intermolecular interaction. Compound 29 and 30 are not gelators.  
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                             Figure 1.14 The illustration of hydrogen bonds in compound 29, arrows indicate 
hydrogen bonds.   
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                                 Figure 1.15 The illustration of hydrogen bonds in compound 30 
 
            The X-ray diffraction (XRD) provides researchers insights of crystal structure and 
gelation. It is now widely used in identification of gel structure.   
 
         Seiji Shinkai’s group did not stop at using small protecting groups at hydroxyl positions. 
They expanded their research by linking to other classes of compounds. The conjugated structure 
of porphyrin provides π-π stacking interaction, but porphyrin is not a gelator in any solvent, 
therefore they introduced carbohydrate in porphyrin.
82
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                                     Figure 1.16 The structure of a porphyrin gelator      
                                                                                            
 
18 
 
              
5,10,15,20-Tetrakis- (4-carboxyl-1-phenyl)porphyrin reacted with  p-aminophenyl-2,3,4,6-
tetra-O-acetyl-α-D-galactopyranoside to give the target molecule. The molecule cannot dissolve 
in most solvents (benzene, toluene, THF, MeCN, anisole water, i-PrOH, n-BuOH, chloroform, 
dichloromethane, n-hexane), but is soluble in DMF. Gelation tests were carried out in mixed 
DMF solvent. The molecule can gel DMF/MeOH, DMF/EtOH, DMF/ i-PrOH at 1:4 ratio, at 3.0 
wt%. In 1:19 ratio DMF/benzyl alcohol mixture, the critical gelation concentration is 0.1 wt%. In 
alcoholic solvent, the molecule tended to form flat structure, which gives more π-π interaction 
and hydrogen bonds. In aprotic solvents, there were more intramolecular interactions and those 
interactions lead to distortion of flat structures.    
 
             Santanu Bhattacharaya’s group also developed a series of tetrameric sugar derivatives. 
An azobenzene core was attached with four carbohydrate modified structures.
83 
                     
                                          Figure 1.17 The derivatives of azobenzene compounds 
 
19 
 
            The gel tests showed that compound 31a is the only one that can form gel in water. The 
resulting solution formed gel immediately at a concentration of 0.1 wt%.  Gelation was also 
tested under various pH conditions, compound 31a can form gel from pH 4 to 10. Different 
solutions (1mM) of NaCl, MgCl2, KCl, CaCl2 were also tested. Compared with spongy globule 
formed in water, in 1 mM CaCl2 it formed rodlike fibers, in 1 mM MgCl2 it formed fibrillar 
globules, and in 1mM NaCl it formed aggregated spheres. The information of fibers was 
confirmed from scanning electron microscope (SEM). SEM is very useful in the gel morphology 
study, although fibers are from xerogel without solvent, it can still provide researchers with 
insights about fiber appearance and how fiber aggregate.     
 
 
           To further study structure and gelation relationship, azobenzene core was changed to bis-
amide derivative of terephthalic acid. Another three compounds were synthesized. However 
none of them can form gel.  
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                                             Figure 1.18 The derivatives of bis-amide azobenzene 
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            In this study π-π stacking from azobenzene and hydrogen bond are the driving force for 
gelation. Circular dichroism (CD) study showed that stacking of azobenzene arranged in a right-
handed helical structure. 
 
          The hydrophobic interaction is one of the most important factors that lead to gelation. The 
carbohydrate itself is usually very polar. To change it, some researchers like Seiji Shinkai 
protected hydroxyl groups. Some others like Santanu Bhattacharaya linked big nonpolar 
molecule to the carbohydrate to balance the polarity. Toshimi Shimizu’s group linked β-hydroxyl 
group of glucose with long chain unsaturated alkane to form aryl glycolipids.
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                                          Figure 1.19 The structures of aryl glycolipids 
 
          The compound 33 could form gels in water/alcohol mixture and several organic solvents. 
The gelation ability decreased with the increasing of unsaturation. Compound 35 cannot form gel 
in any test solvent. The gel sample was made in thin capillaries and X-ray diffraction (XRD) was 
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measured. The results suggested that compounds 33, 34 formed ordered bilayer which packed 
together and trap solvent molecules between them. In the water/alcohol test solvent, the spacing 
for compound 33 and 34 are 3.14 nm and 3.90 nm, respectively. This data is the characteristic of 
π-π stacking. The packing model is shown in Figure 1.20.84 The column represents the long 
alkane chain and solid circle represents sugar group. 
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                                    Figure 1.20 The illustration of molecule packing using compound 34 
 
The same idea is found in a very recent paper. In their case, to balance the polarity they 
used two sugar molecules.
85
 The structure is shown in Figure 1.21. 
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                                               Figure 1.21 The structures of compound 36, 37 
 
       The functional groups that linked to carbohydrate were not just helping gelation, some 
functional groups also bring other applications.  For example, the glucose based naphthalene 
derivatives were synthesized by using hydrazine and diamine linkers.
86
 Four diamine linkers 
were studied. They were ethylenediamine, 1,3-propanediamine, 1,4-butanediamine, and 1,6-
hexanediamine. Five compounds were synthesized and tested in 30 different solvents for 
gelation. 4 compounds can each gel more than 10 solvents. The gelation concentration is 2.5% 
(w/v). 
 
           Fluorescence study was used to compare the gel state and solution state. Gel is measured 
at room temperature, and solution is done at 80°C which is above gel melting temperature.
86
 The 
study showed that the intensity difference is obvious between gel state and solution state. Several 
factors may contribute to these results. The temperature decrease from 80°C to room temperature 
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can lead to immobilization of gelator molecules. Gelation also decreased the mobility of 
molecules. In the end, nonradiative decay of the fluorophore moiety was suppressed and 
therefore fluorescence emission boosted. Structure wise, XRD studies revealed that gelator 
molecules are packed in a J-aggregation pattern which is featured by edge-to-edge π-π stacking 
from naphthalene. The hydroxyl groups of glucose formed hydrogen bonds. Together they 
formed layered structure and depending on the surrounding solvent, the naphthalene moiety will 
face inside or outside to form the tube structure and then the tubes aggregated into fibers leading 
to gelation. 
 
           The examples above showed the modification of one sugar molecule. To take advantage 
of hydroxyl groups which are very useful in hydrogen bonding, researchers introduce multiple 
carbohydrates into one molecule.  
 
           For example, Fraser Stoddart group linked β-cyclodextrin (β-CD) formed by 7 α-D-
glucoses with a modified deoxycholic acid.
87
 The complex 38 was used as a host. The complex 
39 served as guest.       
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                                                        Figure 1.22 The structure of complex 38 
                   
                                                         Figure 1.23 Structure of compound 39  
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The β-CD of host complex interacts with the trans-azobenzene unit of the guest complex 
to form supermolecular inclusion which can form a hydrogel and the gel-sol phase-transition can 
be triggered by light.  
                
                                   Figure 1.24 The illustration of gel and solution change 
 
The reason behind light responsive gel-sol phase-transition is the trans-cis isomerization 
of azobenzene. Under 355nm UV light, the trans-azobenzene lying in the cavity of β-CD was 
photochemically converted into cis-azobenzene and left the cavity. This change made hydrogel 
go to solution state. Under 450 nm visible light, because the process was reversed and 
supermolecular inclusion formed again, the solution was converted to a gel again. Circular 
dichroism further confirmed the gel-sol and sol-gel phase-transition. 
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1.3.2 Other types of Low Molecular Weight Gelators 
Amino acids and peptide based LMWGs 
Amino acids and peptide based gelators are another big class of LMWGs. The structure 
of amino acids and peptides provide hydrogen bond donor and acceptor. The nature 
biocompatible property of amino acids and peptides makes them the best choice in biological 
application. The structure of amino acids usually requires modification to have more Van der 
Waals forces and π-π stacking interaction. L-glycine, L-valine, L-leucine, L-lysine and so on are 
all used to synthesize new LMWGs. Some of these systems are summarized below.  
 
L-lysine is the first amino acid modified to function as a gelator. In 2000, Hirofusa 
Shirai’s group attached different alkyl chains to L-lysine.88,89 The molecules are shown in Figure 
1.25. 
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                            Figure 1.25 Structures of L-lysine Low Molecular Weight Gelators 
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Compound 40 was proved to be an excellent gelator. It formed gel in all 27 test solvents. 
These solvents include polar solvent like MeOH, EtOH, DMSO, unpolar solvents like hexane, 
cyclohexane, oil like silicone oil, salad oil. The minimum gelation concentration varied from 
0.006 g/mL to 0.1 g/mL. Compounds 41 and 42 can gel 20 and 4 solvents, respectively. 
Compound 4 gelled 3 solvents at very high concentrations. The alkyl groups on both sides of the 
L-lysine provide Van der Waals between molecules. Compound 43 is a urea, which has one 
more hydrogen bond donor. This may contribute to the fact that compound 43 recyrstallized out 
in 21 solvents. 
 
            A similar structure modification is found using L-alanine.
90
 The following compounds 
are tested in pure organic solvents; none of them can form gel. But with a little amount of water, 
they can gel 10 different organic solvents.  
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                                  Figure 1.26 The structures of L-alanine LMWGs 
28 
 
           Peptides gelators are usually made of modified amino acids which provide more 
interaction among molecules. A very recent paper from Zhimou Yang group in Nankai 
University studied new peptide hydrogelators in cell culture and cell recovery post culture.
91
 The 
molecules they made by solid peptide synthesizer are shown in Figure 1.27. 
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                                       Figure 1.27 The structure of a modified peptide gelator 
 
           To form a gel, phosphate buffered saline was mixed with the product. Then the reductant 
solution (2 equiv dithiothreitol or glutathione) was added into solution and the S-S bond was 
cleaved. The molecule became Ada-GFFYKn which formed hydrogel within one minute after 
adding reductant solution. Gelator 48a behaved the best among all the four compounds. It 
formed clear gel at 0.5 wt% and stayed stable for more than 3 months. The resulting hydrogel 
could change back to clear solution when M-β-CD was added. This feature was very useful in 
the cell recovery after culture analysis. Mouse embryonic fibroblast cells NIH 3T3 was used in 
cell culture, most cells are alive and the density kept increasing within 3 days period. The 
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separation of cell was done by adding M-β-CD and followed by centrifuge.  Compared with cells 
growing on tissue culture plates, the collected cells from gels behaved normally.    
 
           Small peptides don’t have as many hydrogen bonds, so other modifications were 
considered. Prasanta Kumar Das and his coworkers developed a new series of small peptides 
with Fmoc functional group.
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 The structures are shown in Figure 1.28. 
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                                          Figure 1.28 Structures of small peptides with Fmoc group 
 
           The gelation test was carried out in water. Compounds 49-50d formed gels, which were 
expected by researchers. The minimum gelation concentrations ranged from 0.6 % (w/v) to 2.2 
% (w/v). Compound 51 formed gel at 3.0 % (w/v). Other compounds were not gelators. The tert-
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butyl group at the end of the molecule could not provide the same interaction as the Fmoc group. 
The wide Angle X-ray Scattering of xerogel obtained from compound 50b provided insights of 
packing. The Fmoc group provided π-π interactions between molecules. The distance is 3.5 
angstrom. The phenyl groups of two molecules also interacted with each other by π-π 
interactions. The hydrogen bonds were from peptide bonds.  The molecules packed one on 
another and formed a layer. Those layers also interacted with each other at a distance of 9.5 
angstrom. 
 
Planar macrocyclic molecule based LMWGs 
Planar macrocyclic molecule based LMWGs is another class of gelators. Porphyrins, 
crown-based structures, and steroid are all planar macrocyclic molecules. Because of aromatic 
groups and planar structure, they are perfect for π-π stacking. 
 
Porphyrins  
           In previous section, carbohydrate was used to modify porphyrin structure. Other 
modifications are made by introducing long chain alkyl groups, aromatic ring, ureas, amides, 
carbamates.
93
 Seiji Sinkai’s research group systematically studied different attachments for 
porphyrin. In 2004, they published a paper in JACS about using long alkyl chain amide.
94
 The 
structures are shown in Figure 1.29. 
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                                            Figure 1.29 The structures of porphyrin LMWGs 
 
 Compounds 52 and 53 were excellent gelators with or without metal. Compound 54 did 
not gel any test solvents. Compound 55 formed gels in cyclohexane and decahydronaphthalene 
(Decalin). The gel in decalin showed thixotropic behavior. After the gel was shaken and broken 
into solution, it can reform gel without heating again. This implies that gel fibers are stable, 
extremely thin and extended.  
 
More structure variations were explored by Seiji Sinkai research group. The urea 
structure is usually considered very efficient in forming hydrogen bonds. These compounds 
below show very good gelation property. The study also showed that porphyrin not just pack in 
one-dimension. Compound 52 gave a one-dimension packing, but compound 59 aggregated in a 
two-dimension fashion.
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                               Figure 1.30 The structures of urea porphyrin LMWGs    
          
       Compound 58 also showed a special 2-dimensional packing. It consisted of two different 
hydrogen bonds.   
 
Crown-structure 
          The crown structures like cryptand, 18-crown-6, dibenzo-18-crown-6 were also studied. In 
the early period, crown ethers were linked with cholesterol to make gelators. The use of 
cholesterol was mainly to increase the interaction among molecules. Seiji Shinkai’s research 
group developed a new type of crown-based gelator without cholesterol.
96 
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                                           Figure 1.31 The structures of crown ether LMWGs 
 
           Compound 61 and 62 could form gel in benzene and m-xylene at 5.0 wt %. With the 
addition of compound 63, mixtures of 61, 63 and 62, 63 both formed gels in two more solvents. 
With the addition of compound 64, mixtures of 61, 64 and 62, 64 both formed gel in one more 
solvent. Other solvents like methanol, THF, DMF were tested too. But the gelation only 
happened in aromatic solvents. Further study showed that the interaction between crown based 
molecules with guest were charge-transfer interaction.   
 
Aromatic ring system  
      Conjugate aromatic rings like perylene, coronene are another type of planar macrocyclic 
molecules. There are examples of tetraester coronene, imidoester coronene as liquid crystals. 
34 
 
Subi J. George research group used charge-transfer interaction to design coronene based 
hydrogel.
97
 The structures are shown in Figure 1.32. Different acceptors are screened. 
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                                Figure 1.32 The structures of aromatic based LMWGs     
             
           CS-DMV complex formed a transparent dark-red hydrogel. AFM study showed that fibers 
are 10-15 µm long and 100-300 nm in diameter. The gel stayed stable for several months. The X-
ray study showed that CS and DMV featured in a face to face aggregation. 
 
Steroid 
          Steroid based gelator is another class of planar macrocyclic based LMWGs. The research 
of steroid based gelator begun very early, which provides us a good understanding of structure 
and gelation relationship. Among different steroids, cholesterol and anthraquinone are well 
studied, because the hydroxyl group provides modification options. Long chain structures and 
aromatic ring systems were first explored.  Structure 70 was the research result from Shin 
35 
 
Shinkai’s research group.98 They attached the long chain functional group to the C3 position in 
both R and S isomers. The stereochemistry at C3 position made a big difference. The compounds 
with S chirality (natural chirality) showed limited gelation property. But compounds with R 
chirality behaved much better and they can form gels in more solvents and at much lower 
concentration (<1 mg/mL).   
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                                     Figure 1.33 The structures of steroid based LMWGs 
 
              Richard G. Weiss research group studied the aromatic attachment of cholesterol, 
anthracene, naphthyl, phenyl group were linked with other functional groups like ester, 
carbamate to cholesterol.
99-101
 
36 
 
                                        
O
O
X
X             n
O 3
No atom 0
71
72
n
                    
                                    
O
O
H
N O
O
H
N
73 74
O
O
N
O
O
75  
                                          Figure 1.34 Structures of steroid based LMWGs      
           Compound 71 and 72 were very good gelators in different organic solvents.  Compound 
73, 74, 75 formed gel in some long alkyl solvents like n-dodecane, n-hexadecane and some 
alcohols like 1-propanol, 1-butanol, 1-pentanol. From the spectroscopy study, there was no 
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hydrogen bonding in the gels, so it proved the importance of aromatic groups. Weiss research 
group also studied different steroids with the same aromatic group at C3 position. The variation 
focused on different alkyl group attached to C17 position. The results showed small changes in 
C17 position did not have much effect in gelation and branched alkyl group gave better gelation 
results. 
 
1.4 Applications of Low Molecular Weight Gelator 
          We have seen lots of applications from nature polymers like alginate, chitosan, fibrin, 
hyaluronate, collagen, gelatin and synthetic polymers like poly(acrylic acid), poly(vinyl alcohol), 
polyphosphazene. The applications of LMWGs are mostly on laboratory level and models study, 
but scientists have been working on the improvements of gelation condition, synthetic routes, 
toxicity, etc. There are more and more publications in different applications especially in 
nanomaterials and biological area.   
 
1.4.1 LMWGs in Nanomaterials 
          The nano-scale gel fibers are very similar to nanotubes. The porous structure formed by 
fibers can be used as structure directing agents for nanoporous materials. The silica based nano 
structure has been well studied.
102-104
 To efficiently transfer gel fiber structure to silica, 
interaction between gel fibers and silica is required. Tetraethyl orthosilicate (TEOS) has been 
used in this study. Arindam Banerjee used a small amount of amino acid and graphene oxide to 
form a stable hydrogel. An aqueous solution of graphene oxide at 22 mg/mL was mixed with 50 
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µL HAuCl4 (25 mM) and then the right amount of tryptophan was added. The solution was 
stirred well and sonicated to obtain a hydrogel. The addition of tryptophan was to reduce Au
3+ 
to 
Au. This in situ Au nanoparticles formation is greener than the old method, which was done in 
solution by mixing graphene oxide with metal salt solution and followed by reducing agent 
(borohydride, hydrazine, etc) or stabilizing agent. Jianbin Huang research group reported the 
synthesis of photoluminescent lanthanide-organic hybrid nanofibers in hydrogels. They used 
europium-cholate hybrid hydrogel to transcribe europium-doped silica nanotubes. Basically, 
sodium cholate, europium ion, ammonium, tetraethyl orthosilicate (TEOS) were mixed well into 
solution. Due to hydrophobic effect and metal coordination, a hydrogel formed. The excess Eu
3+
 
gathered on the surface of fibers and then negative charged silica oligomers were drawn onto 
fiber surface by electrostatic attraction. When the amount of silica oligomers reached certain 
level, silica polycondensation occurred and silica nanotube network formed. The gel was 
destroyed afterwarda and the product was collected and calcined.  
 
           For nanoporous structure, Seiji Shinkai research group did most the early work and they 
continue to explore new gelators for nanostructure.
105
 The β-glucose based LWMGs can gel  
water/ethanol mixture and the morphology at different concentrations was studied. For 
compound 76, at 3.0 wt% in water, fiber thicknesses varied from 400 to 600 nm. At 0.1 wt%, 
thicknesses ranged from 20 to 30 nm. The solution-gel polymerization transcribed gel fiber 
structure onto silica. The resulting silica nanotube had two different diameters. The one from 3.0 
wt% gel was 450-600 nm and the one from 0.1 wt% was 20-25 nm.  
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            This result showed that the nanotube structure can be controlled by gelation 
concentration. It proved the possibility of encaging suitable materials in the nano structure. 
 
1.4.2 Low molecular weight gelators in biological applications 
The applications of LMWGs in biological area are very promising, especially for gelators 
based on carbohydrates, amino acids, nucleotides, and nucleosides. They can be used in 
controlled drug release, enzyme immobilization, etc. Different models of controlled drug release 
have been studied. Jan van Esch research group studied small molecules, 8-aminoquinoline (AQ) 
and 2-hydroxyquinoline (HQ), as model drug molecules.
106  
The gel was formed by N, N-
dibenzoyl-L-cystine (DBC) in 150 mM NaCl solution, PBS (phosphate-buffered saline at pH 
7.4) and water. The AQ or HQ was mixed with gelator in test solvents. After heating and cooling 
process, gel formed and then same solvent was added on top of the gel to monitor the release. 
The top solvent was analyzed by UV-vis spectroscopy to determine the release amount. The 
study showed that release of AQ was slower than that of HQ. Because the interaction between 
AQ and gelators were stronger due to the amino group of AQ and carboxylic acid group of 
gelator molecule. Only for AQ, the initial release rate was related with gel degradation rate. 
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Peptide based LMWGs were studied for drug controlled release, too.
107
 Takatoshi Kinoshita 
research group studied self-assembling peptide RADAFI system and RADAFII system. Peptides 
mixed with model molecule to form gel and a buffer solution was added on top of the gel. The 
release was monitored by UV-vis every 30 minutes. The release process was controlled by 
Fickian diffusion. The AFM study showed the packing was different for the two systems due to 
aromatic groups of peptides. The packing difference also resulted in the difference of model drug 
release. Large model drug was easier to release from RADAFI.    
                      
            Enzyme immobilization is another important application for LMWGs. The gel’s porous 
structure meets the space requirement of big protein. Besides, biocompatibility of LMWGs can 
maintain protein’s activity. Bing Xu research group has done extensive study in this area.108 
They studied the combination of LMWGs (Fmoc-L-phenylalanine and Fmoc-L-lysine) with 
different Heme model compounds. To test the activity of peroxidase (Heme served as active 
center ), Xu et al studied oxidation of pyrogallol. The hydrogel based artificial enzyme show the 
highest activity in toluene. It is 90% of the activity of native horseradish peroxidase in water. 
 
Other applications of LMWGs are tissue engineering, controlled release of biological 
agents, liquid crystalline materials, biosensing, and environment remediation and so on. More 
and more LMWGs are synthesized and characterized every year. More and more applications of 
LMWGs will be available not only in laboratory study but also in industry and daily life.     
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                                                                                   Chapter II 
 Synthesis and Gelation Properties of 1-Deoxy-D-Glucopyranoside Ester Derivatives and β-
Phenyl-D-Glucopyranoside Ester Derivatives  
 
Abstract: D-Glucose has been modified to obtain effective low molecular weight gelators. 
Previously, our group investigated 4, 6-O-benzylidene-methyl-α-D-glucopyranoside and 
modified the structure by introducing ester functional groups on 2, 3-hydroxy groups. The 
gelation test results showed several excellent gelators. To further investigate structure and 
gelation relationship, we studied the effect of anomeric position. In this chapter, two different 
headgroups are studied, 4, 6-O-benzylidene-deoxy-α-D-glucopyranoside 1 and 4, 6-O-
benzylidene-β-phenyl-D-glucopyranoside 2. The esterificaton were carried out at 2, 3 positions. 
The long chain alkyl groups, terminal alkynes, aromatic groups were attached to the head groups. 
Their gelation properties were tested. 
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Keywords: low molecular weight gelator, D-glucose. 
Part of this chapter is adapted from reference 21.  
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                                                               Introduction 
The natural abundance and biocompatibility make carbohydrate based LMWGs the best 
candidate for biological applications.
1-15
 Seiji Shinkai’s group from Kyushu University is the 
first group systematically studied gelation properties of different sugars like mannose, glucose, 
allose, altrose.
16, 17
 They not only studied the protected 4, 6 position but also invested α, β 
difference at anomeric position. However modifications at 2, 3 positions were not explored 
much. 
The previous work done by our group studied the ester functional group at 2, 3 positions. 
4, 6-O-benzylidene-methyl-α-D-glucopyranoside was treated with different acyl chlorides.18, 19 
The reaction usually gave three products: diester, 2-monoester, 3-monoester, as shown in 
Scheme 2.1. 
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                                 Scheme 2.1 The synthesis of ester derivatives of compound 3 
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The gel tests showed that the diesters of phenyl and naphthyl were very good gelators in 
EtOH/H2O=1:1 mixture. However the straight chain alkyl derivatives didn’t behave very well. 
The following paper from our group further explored structure and gelation relationship. Base on 
the same head group, terminal alkyne esters and carbamates were synthesized.
20, 21 
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                               Figure 2.1 The structures of different terminal alkyl derivatives 
 
The terminal alkyne behaved much better. Four diesters formed gel in hexane and 6 
monoesters formed gel in both water and hexane. The minimum gelation concentrations for 3 
compounds were only 3 mg/mL in hexane.  
                          
n
O
O
O
O
OPh
OCH3
O
NHO
NH
n= 1, 3
O
O
HO
O
OPh
OCH3O
NH
O
O
O
OH
OPh
OCH3
O
NH
5A 5B 5C
n n
n
                     
                                    Figure 2.2 The structures of carbamates compounds 
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Two carbamate compounds formed gel in water and hexane separately. When we look 
into the structure of these sugar derivatives, we can draw the following conclusions. The 
aromatic protection group at 4, 6 positions provide π-π stacking. If there is no functional group at 
2, 3 positions, the hydroxyl group will form hydrogen bonding which is proved by X-ray 
diffraction.
22
 When the 2 position was functionalized, there is hydrogen bonding between 3-
hydroxyl group and oxygen next to the anomeric position.  
 
            To study the structure and gelation relationship, we want to know the effect of the 
anomeric position methoxyl group.  We decided to remove the methoxy group in 3 and this leads 
to compound 1. We also want to know how α and β conformation affect gelation, so so the 
methoxy group was replaced by a phenoxyl group which gave 4, 6-O-benzylidene-β-phenyl-D-
glucopyranoside 2. 
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                                             Figure 2.3 Structure of compound 1 and 2 
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                                                        Results and Discussion 
The synthesis of compound 1 followed the method from our previous paper.
23
 The head 
group reacted with acyl chloride to give three products. 
R=
O
O
HO
OH
OPh
1
RCOCl
DCM, py
rt, ~20h
O
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O
R O
R
O
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O
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O
R
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R
A B C
6 7 8
9 10
11
12
                           
                           Scheme 2.2 Synthesis of esters LOWGs library of compound  
To obtain three products in one pot, the acyl chloride was 1.2 equivalents compared with 
the head group. Some acyl chlorides of R groups were made in situ. Those include 11, 12.  The 
reactions were done in room temperature after around 20 hours. Except naphthyl only gave 
diester and 2-monoester, all other reactions gave three products. Due to the acyl chloride amount 
used, the yield of diester (A) product is usually low. The products were purified by flash 
chromatography. The detailed yields are showed in Table 2.1. 
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                   Table 2.1 The yields of of three ester products a, b, c. 
        
Compound 
Total yield O
O
O
O
OPh
O
R
O
R
a  
O
O
HO
O
OPh
O
R
b  
O
O
O
OH
OPh
O
R
c  
6 73 % 18 % 32 % 23 % 
7 64 % 12 % 32 % 20 % 
8 82 % 38 % 23 % 21 % 
9 70 % 33 % 37 % -- 
10 59 % 8.0 % 19 % 32 % 
11 63% 6 % 33 % 24 % 
12 84% 11 % 46 % 27 % 
 
    
 
The selectivity between 2-monoester and 3-monoester was not significant. The lost of 
methoxyl group at anomeric position had influenced the selectivity. When there was methoxyl 
group, 2 position hydroxyl group can form hydrogen bond with methoxyl group and 2 position 
can be deprotonated more easily. Gel formation was tested in five solvents: water, hexane, 
ethanol, EtOH/H2O (1: 2) and DMSO/H2O (1: 2). 2 mg sample was added into a small vial 
followed by 0.1 mL test solvent. Heat was used to solvate the sample if necessary. The vial was 
cooled to room temperature for about 15 minutes. Then it was inverted to check whether solvent 
54 
 
was held or not. If gel forms, a series of dilution was carried out until gel collapses to find out the 
minimum gelation concentration. If gel does not form, the status is recorded as soluble, 
precipitate, insoluble, etc. The gel tests results of compound 1 derivatives are shown in Table 2.2 
and 2.3. 
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                            Table 2.2 Gelation test results for ester derivatives of 1. 
Compound Hexane H2O EtOH EtOH:H2O (1:2) DMSO:H2O (1:2) 
6A S P S P P 
6B P P S P P 
6C P P S S P 
7A S P S S P 
7B P P S P P 
7C P P S P P 
8A S P S P P 
8B P P S P P 
8C P P S P P 
 
All concentrations are in mg/mL; G, gel at room temperature; the numbers after G are minimum 
gelation concentrations; P, precipitation; S, soluble at~20 mg/mL; the ratios of solvents are in 
parenthesis. 
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                           Table 2.3 Gelation test results for ester derivatives of 1. 
Compound Hexane H2O EtOH EtOH:H2O(1:2) DMSO:H2O(1:2) 
9A I P G 5 P G5 
9B I P S G 4 P 
9C I P S G 10 G 20 
10A I P P P G 20 
10B I P S P P 
11A S P G 7 P P 
11B P P S P P 
11C P P S P P 
12A P P G 3 P P 
12B P P S P P 
12C P S S P P 
 
 
All concentrations are in mg/mL; G, gel at room temperature; the numbers after G are minimum 
gelation concentrations; P, precipitation; S, soluble at~20 mg/mL; the ratios of solvents are in 
parenthesis. 
  
From the above gelation tests results, we can draw some conclusions. The 5, 6, 7 carbon 
alkyl group esters did not form any gel. This result was consistent with gelation property of short 
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chain alkyl esters of 4, 6-O-benzylidene-methyl-α-D-glucopyranoside. If the alkyl group is too 
short, the interaction (van der Waals force) is not strong enough for one dimensional network 
formation. On the other hand, two of long chain diacetylene esters formed gel in ethanol at 3 
mg/mL and 7 mg/mL separately. The aromatic esters are good gelators. Dimer of benzyl ester 
9A formed gel at 5 mg/mL in both ethanol and DMSO: H2O (1: 2). The 2-isomer of benzyl ester 
9B formed gel at 4 mg/mL in EtOH: H2O (1: 2). The 3-isomer 9C gelled in EtOH: H2O (1: 2), 
DMSO: H2O (1: 2) at 10 mg/mL and 20 mg/mL separately. This result was significantly different 
from gelation results of benzyl esters of 4, 6-O-benzylidene-methyl-α-D-glucopyranoside. In that 
series, only the dimer of benzyl ester 13 formed gel in EtOH: H2O (1: 1) at 7 mg/mL. However 
the dimer of naphthyl group 13a from that series behaved better than the one in deoxy-glucose 
series which formed gel in DMSO: H2O (1: 2) at 20 mg/mL.  
 
                                       
O
O
O
O
OPh
O
O OCH3
O
O
O
O
OPh
O
O OCH3
13 13a  
                                       Figure 2.4 The structures of compounds 13 and 13a 
 
The gel morphology was studied using an Olympus BX60 microscope and a JEOL JSM 
5410 scanning electron microscope. The optical images below show that fibers in the gel hold 
the solvent.
21
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Figure 2.5 The image of 9B in EtOH/H2O (1:2) at 4 mg/mL. The images were taken with gels 
containing solvents (not dried gels). 
 
Because of diacetylene functional groups in compound 11 and 12, it can be polymerized 
under UV light or heat. Figure 2.7 shows how polymerization works. 
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                               Figure 2.6  The polymerization of diacetylene 
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            The polymerization changes the color of a clear gel to blue. The blue and purple fibers 
can been seen from Figures 2.7.
21
 The SEM image of the zerogel showed long and thin fibers.
21
  
 
 
Figure 2.7 Optical micrographs under bright field (a, b) and scanning electron micrograph (c) of 
the gel formed by compound 12A in ethanol after exposure to UV light for 3 min. 
 
 
                                   
 
 
Figure 2.8 Scanning electron micrograph (c) of the gel formed by compound 12A in ethanol after 
exposure to UV light for 3 min          
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From the functionalization of 4, 6-O-benzylidene-methyl-α-D-glucopyranoside 3 and 4, 
6-O-benzylidene-deoxy-α-D-glucopyranoside 1, we learned that the terminal alkynes esters, 
aromatic esters, long chain diacetylenes are very good functional groups for gelators. To further 
explore the gelators structures and understand the influence of the anomeric substituents we 
studied sugar head group 4, 6-O-benzylidene-β-phenyl-D-glucopyranoside 2, which is 
commercially available. We decided to use terminal alkynes esters and long chain diacetylenes. 
We didn’t synthesized aromatic esters, because two aromatic groups are enough for π-π stacking. 
The structures of functional groups are shown below. All the acyl chlorides (14, 15, 16, 17, 18) 
are made in situ. In these reactions, only two products were obtained. There is no 3-monoester 
product. The yields are shown in the Table 2.4. The gel tests results are shown in the Table 2.5. 
            
 
                                         
                              Scheme 2.3 Synthesis of esters LMOGs of compound 2 
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                                          Table 2.4 The yields of ester a, b of compound 2 
Compound    Total yields 
O
O
O
O
OPh
O
R
O
R
OPh
a  
O
O
HO
O
OPh
O
R
OPh
b  
14 75 % 30 % 45 % 
15 83 % 20 % 63 % 
16 72 % 30 % 42 % 
17 68 % 5 % 63 % 
18 69 % 4 % 65 % 
    
              In this series, no 3-monoester was obtained in the reaction. The possible explanation is 
β-phenoxyl group is an electron withdrawing group which makes 2 position hydroxyl group 
easier to lose hydrogen and attack acyl chloride. After the 2-position was activated, 3-position 
was easier to be approached. That is why some reactions produced fair amount of diesters. 
 
 
 
 
 
62 
 
                            Table 2.5 Gelation test results of for ester derivatives of 2. 
Compound Hexane H2O EtOH EtOH: 
H2O 
(1:2) 
DMSO: 
H2O 
(1:2) 
iPrOH Toluene EtOH:
H2O 
(1:1) 
14A I P S P P S S P 
14B I P S G 7 G 7 S S G 20 
15A I P S P P S S P 
15B I P S G 5 P S S P 
16A I I S I I P S G 20 
16B I I S G 3 I S S P 
17A I P P P P S S P 
17B I P S P P P S P 
18A I P P P P S S P 
18B I P S P P S S P 
  
 
All concentrations are in mg/mL; G, gel at room temperature; the numbers after G are minimum 
gelation concentrations; P, precipitation; S, soluble at~20 mg/mL; the ratios of solvents are in 
parenthesis. 
 
             Terminal alkyne esters had similar gelation property compared with alkyne esters of 4, 
6-O-benzylidene-methyl-α-D-glucopyranoside. The 2-monoester of 5 carbon terminal alkyne 
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ester 14B formed gel at 7 mg/mL in both EtOH: H2O (1: 2) and DMSO: H2O (1: 2). 2-monoester 
of 6 carbon alkyne ester 15B formed gel in EtOH: H2O (1: 2) at 5 mg/mL. 2-monoester of 7 
carbon terminal alkyne ester 16B behaved best and gelled EtOH: H2O (1: 2) at 3 mg/mL.  It 
seemed that gelation improved as the chain length of terminal alkynes increased. The four esters 
of long chain diacetylene 17A, 17B, 18A, 18B did not form any gel. The phenyl group at 
anomeric position might affect the gelation tendency of these long chain lipids.  
 
            The gels formed by these compounds were characterized with optical micrographs, as 
shown in Figures 2.9-2.113. Typically they form fibers as shown in Figure 2.10 and 2.11. But it 
also depended on the compounds. For example, compound 15B formed flower like structures 
with short tubes. On the other hand, compound 14B formed sheets, and if we look closer, we can 
see the sheet was made by tubes packing together. 
                 
Figure 2.9 500x Optical micrographs of gel formed by Compound 15B at 5mg/mL in 
DMSO/H2O (1: 2).  
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Figure 2.10 200x Optical micrographs of gel formed by compound 14B at 6.7mg/mL in 
DMSO/H2O (1: 2).  
 
                 
Figure 2.11 500x Optical micrographs of gel formed by Compound 14B at 6.7mg/mL in 
DMSO/H2O (1: 2).  
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Figure 2.12 200x Optical micrographs of gel formed by compound 14B at 6.7mg/mL in 
EtOH/H2O (1: 2). 
 
 
                  
Figure 2.13 500x Optical micrographs of gel formed by Compound 14B at 6.7mg/mL in 
EtOH/H2O (1: 2).  
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                                                                 Conclusion  
We systematically studied the ester functional groups at 2, 3 positions in different sugar 
derivatives 1, 2, 3. The ester functional groups include aromatic groups, straight chain alkyls, 
terminal alkynes, and long chain diacetylenes.  
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The gelation tests showed that esters of terminal alkynes usually formed gel in different 
solvents like water, ethanol, EtOH: H2O (1:2) and DMSO: H2O (1: 2). On the other hand, 
straight chain alkyl esters didn’t behave well. The aromatic functional groups are phenyl and 
naphthyl groups. Their esters were very good gelators. The minimum gelation concentration 
reached 4 mg/mL. The long chain diacetylene esters of compound 2 were very good gelators in 
ethanol. 
 
           In the design of gelators, the balance of different interactions was critical. Even if the 
chain length was the same, the terminal alkyne esters were much better gelators than alkyl esters. 
The alkyne chain was more rigid, which was easier for molecular packing. The aromatic groups 
usually could provide π-π stacking. However if π-π stacking and van der Waals forces were too 
much, it would lead to precipitation. This could be seen in the diacetylene dimer of compound 2. 
The hydrogen bonding was not very critical among these esters. The common one was the 
hydrogen bonding between 2 or 3 position hydroxyl group and the oxygen next to the anomeric 
carbon. 
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                                                       Experimental section 
              Materials and Instruments: General chemicals and reagents were purchased from 
Aldrich, or VWR. The diacetylene containing fatty acids were purchased from GFS chemicals. 
Optical microscope images were recorded with an Olympus BX60 microscope and CCD camera. 
NMR spectra were recorded using a 400 MHz Varian NMR spectrometer. High resolution mass 
spectrometry data were measured on the Q-Tof of the Mass Spectrometry lab at the University of 
Illinois after the low resolution masses were confirmed. The ionization technique used was ESI 
(electrospray ionization). Melting points were measured using a Fisher-Jones melting point 
apparatus. 
 
            Optical microscopy. The sample was prepared as a small piece of gel placed on a clean 
microscope glass slide, and the gel was imaged directly under the microscope. The program used 
to acquire and store the photos was Corel Photo-Paint 7. 
 
           Scanning electron microscopy. A piece of the gel was deposited on an aluminum sample 
holder and allowed to dry in a desiccator. The dried gel sample was coated with a thin layer of 
platinum (~100–150 Å) by a Denton Vacuum (model Desk II) at a reduced pressure of ~30 
mTorr and a current of 45 mA for 60 sec. The sample was analyzed using a JEOL JSM 5410 
scanning electron microscope with an EDAX Detecting Unit PV9757/05 ME (Model 204B+, 
active area = 10 mm
2
). 
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General procedure for ester synthesis: 
            Sugar head group (80-100 mg) was mixed with 5 molar equivalents of anhydrous 
pyridine in 2 mL DCM/THF. The mixture was stirred and cooled in ice bath. 1.2 molar 
equivalents of acyl chloride were added dropwise. Then the mixture was left at room temperature 
for 15-20 hours. A NMR sample was taken to confirm that reaction was done. The common 
workup procedure was to dilute the reaction mixture with about 5 mL water followed by 
extraction with DCM (3x 10mL). The DCM phase was combined and dried with sodium sulfate. 
The crude product was purified by flash chromatography. 
 
            Compound 6A (30 mg, 18%), white solid, mp 71.0–72.0 °C. 1H NMR (400 MHz, CDCl3) 
δ (ppm) 7.40–7.46 (m, 2H), 7.32–7.37 (m, 3H), 5.50 (s, 1H), 5.36 (t, 1H, J = 9.5 Hz), 5.05 (m, 
1H), 4.34 (dd, 1H, J = 4.9, 10.5 Hz), 4.12 (dd, 1H, J = 5.9, 11.0 Hz), 3.72 (t, 1H, J = 10.3 Hz), 
3.63 (t, 1H, J = 9.5 Hz), 3.47 (dt, 1H, J = 4.8, 9.5, 9.9 Hz), 3.39 (t, 1H, J = 10.8 Hz), 2.26–2.34 
(m, 4H), 1.52–1.64 (m, 4H), 1.23–1.38 (m, 4H), 0.90 (t, 3H, J = 7.3 Hz), 0.94 (t, 3H, J = 7.3 Hz). 
13
C NMR (100 MHz, CDCl3) δ (ppm) 172.8, 136.9, 129.0, 128.2, 126.0, 101.3, 78.9, 72.0, 71.4 
69.3, 68.6, 67.5, 33.9, 33.7, 27.0, 26.8, 22.1, 22.0, 13.6. HRMS Calcd for C23H33O7 [M + H]
+ 
420.2226, found 421.2217. 
 
            Compound 6B (42 mg, 32%); white solid; 107.0–109.0 °C. 1H NMR (400 MHz, CDCl3) 
δ (ppm) 7.47–7.52 (m, 2H), 7.35–7.41 (m, 3H), 5.55 (s, 1H), 4.95 (ddd, 1H, J = 5.9, 9.2, 10.6 
Hz), 4.33 (dd, 1H, J = 5.1, 10.6 Hz), 4.12 (dd, 1H, J = 5.9, 11.0 Hz), 3.92 (t, 1H, J = 9.2 Hz), 
3.71 (t, 1H, J = 10.3 Hz), 3.55 (t, 1H, J = 9.2 Hz), 3.40 (dt, 1H, J = 4.8, 9.5 Hz), 3.30 (t, 1H, J = 
69 
 
10.8 Hz), 2.62 (s, 1H), 2.37 (m, 2H), 1.62 (m, 2H), 1.36 (m, 2H), 0.92 (t, 3H, J = 7.3 Hz). 
13
C 
NMR (100 MHz, CDCl3) δ (ppm) 173.4, 136.9, 129.3, 128.4, 126.3, 101.9, 81.2, 72.9, 71.5, 
71.0, 68.7, 67.3, 33.8, 26.9, 22.1, 13.7. HRMS Calcd for C18H25O6 [M + H]
+
 337.1651, found 
337.1644. 
 
              Compound 6C (31 mg, 23%); white solid; mp 72.0–74.0 °C. 1H NMR (400 MHz, 
CDCl3) δ (ppm) 7.42–7.48 (m, 2H), 7.33–7.38 (m, 3H), 5.51 (s, 1H), 5.00 (t, 1H, J = 9.2 Hz), 
4.35 (dd, 1H, J = 4.8, 10.6 Hz), 4.11 (dd, 1H, J = 5.9, 11.4 Hz), 3.83 (m, 1H), 3.70 (t, 1H, J = 
10.3 Hz), 3.61 (t, 1H, J = 9.3 Hz), 3.44 (dt, 1H, J = 4.8, 9.9 Hz), 3.39 (t, 1H, J = 11.0 Hz), 2.95 
(d, 1H, J = 4.4 Hz), 2.41 (t, 2H, J = 7.5 Hz), 1.63 (pentet, 2H, J = 7.5 Hz), 1.34 (hex, 2H, J = 7.5 
Hz), 0.87 (t, 3H, J = 7.5 Hz). 
13
C NMR (100 MHz, CDCl3) δ (ppm) 175.7, 136.9, 129.1, 128.2, 
126.1, 101.4, 78.4, 77.1, 71.4, 70.6, 70.1, 68.8, 34.1, 27.0, 22.1, 13.6. HRMS Calcd for C18H25O6 
[M + H]
+
 337.1651, found 337.1646. 
 
             Compound 7A (22 mg, 12%); white solid; mp 37.0–38.0  °C. 1H NMR (400 MHz, 
CDCl3) δ (ppm) 7.40–7.46 (m, 2H), 7.32–7.38 (m, 3H), 5.50 (s, 1H), 5.36 (t, 1H, J = 9.5 Hz), 
5.05 (ddd~dt, 1H, J = 5.9, 9.5, 10.3 Hz), 4.34 (dd, 1H, J = 4.9, 10.5 Hz), 4.12 (dd, 1H, J = 5.9, 
11.2 Hz), 3.72 (t, 1H, J = 10.3 Hz), 3.63 (t, 1H, J = 9.5 Hz), 3.47 (dt, 1H, J = 5.1, 9.9 Hz), 3.39 
(t, 1H, J = 10.8 Hz), 2.25–2.37 (m, 4H), 1.53–1.64 (m, 4H), 1.20–1.36 (m, 8H), 0.89 (t, 3H, J = 
7.0 Hz), 0.82 (t, 3H, J = 7.0 Hz). 
13
C NMR (100 MHz, CDCl3) δ (ppm) 172.8, 136.9, 129.0, 
128.2, 126.0, 101.4, 78.9, 72.0, 71.5, 69.4, 68.6, 67.5, 34.3, 34.0, 31.15, 31.1, 24.7, 24.5, 22.2, 
13.9, 13.8. HRMS Calcd for C25H37O7 [M + H]
+
 449.2539, found 449.2538.  
70 
 
               Compound 7B (44 mg, 32%); white solid; mp 112.0–114.0 °C. 1H NMR (400 MHz, 
CDCl3) δ (ppm) 7.46–7.53 (m, 2H), 7.35–7.42 (m, 3H), 5.55 (s, 1H), 4.95 (m, 1H), 4.33 (dd, 1H, 
J = 4.8, 10.6 Hz), 4.12 (dd, 1H, J = 5.7, 11.2 Hz), 3.91 (t, 1H, J = 9.2 Hz), 3.71 (t, 1H, J = 10.3 
Hz), 3.54 (t, 1H, J = 9.3 Hz), 3.40 (dt, 1H, J = 4.8, 9.5 Hz), 3.30 (t, 1H, J = 10.8 Hz), 2.64 (s, 
1H), 2.36 (m, 2H), 1.64 (p, 2H, J = 7.3 Hz ), 1.31 (m, 4H), 0.90 (t, 3H, J = 6.8 Hz). 
13
C NMR 
(100 MHz, CDCl3) δ (ppm) 173.4, 136.9, 129.3, 128.3, 126.2, 101.9, 81.2, 72.8, 71.5, 71.0, 68.7, 
67.3, 34.1, 31.2, 24.5, 22.3, 13.9. HRMS Calcd for C19H27O6 [M + H]
+
 351.1808, found 
351.1801.  
 
              Compound 7C (27 mg, 20%); white solid; mp 113.0–114.0 °C. 1H NMR (400 MHz, 
CDCl3) δ (ppm) 7.42–7.48 (m, 2H), 7.33–7.39 (m, 3H), 5.51 (s, 1H), 5.01 (t, 1H, J = 9.2 Hz), 
4.35 (dd, 1H, J = 4.9, 10.5 Hz), 4.11 (dd, 1H, J = 5.7, 11.5 Hz), 3.83 (m, 1H), 3.70 (t, 1H, J = 
10.3 Hz), 3.61 (t, 1H, J = 9.5 Hz), 3.44 (dt, 1H, J = 4.8, 9.9 Hz), 3.39 (t, 1H, J = 10.8 Hz), 2.98 
(sb, 1H), 2.40 (t, 2H, J = 7.3 Hz), 1.65 (m, 2H), 1.22–1.36 (m, 4H), 0.84 (t, 3H, J = 7.0 Hz). 13C 
NMR (100 MHz, CDCl3) δ (ppm) 175.7, 137.0, 129.1, 128.2, 126.1, 101.4, 78.4, 77.1, 71.4, 
70.6, 70.1, 68.8, 34.3, 31.1, 24.7, 22.2, 13.8 HRMS Calcd for C19H27O6 [M + H]
+
 351.1808, 
found 351.1801. 
 
             Compound 8A (72 mg, 38%); white solid; mp 49.0–50.0 °C. 1H NMR (400 MHz, 
CDCl3) δ (ppm) 7.40–7.46 (m, 2H), 7.32–7.38 (m, 3H), 5.49 (s, 1H), 5.36 (t, 1H, J = 9.5 Hz), 
5.05 (ddd, 1H, J = 5.9, 9.5, 10.3 Hz), 4.34 (dd, 1H, J = 4.9, 10.5 Hz), 4.12 (dd, 1H, J = 5.9, 11.0 
Hz), 3.71 (t, 1H, J = 10.3 Hz), 3.63 (t, 1H, J = 9.5 Hz), 3.47 (dt, 1H, J = 4.8, 9.9 Hz), 3.38 (t, 1H, 
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J = 11.0 Hz), 2.24–2.37 (m, 4H), 1.53–1.64 (m, 4H), 1.17–1.36 (m, 12H), 0.88 (t, 3H, J = 7.0 
Hz), 0.84 (t, 3H, J = 7.0 Hz). 
13
C NMR (100 MHz, CDCl3) δ (ppm) 172.79, 172.76, 136.9, 
128.9, 128.1, 126.0, 101.3, 78.8, 72.0, 71.4, 69.3, 68.6, 67.4, 34.2, 34.0, 31.4, 31.3, 28.64, 28.60, 
24.9, 24.7, 22.4, 22.3, 14.0. HRMS Calcd for C27H41O7 [M + H]
+
 477.2852, found 477.2847.  
 
              Compound 8B (33 mg, 23%); white solid; mp 102.0–104.0 °C. 1H NMR (400 MHz, 
CDCl3) δ (ppm) 7.46–7.53 (m, 2H), 7.35–7.42 (m, 3H), 5.55 (s, 1H), 4.95 (ddd, 1H, J = 5.9, 9.2, 
10.3 Hz), 4.34 (dd, 1H, J = 5.1, 10.6 Hz), 4.12 (dd, 1H, J = 5.9, 11.0 Hz), 3.92 (t, 1H, J = 9.2 
Hz), 3.71 (t, 1H, J = 10.3 Hz), 3.55 (t, 1H, J = 9.2 Hz), 3.40 (dt, 1H, J = 5.0, 9.7 Hz), 3.30 (t, 1H, 
J = 10.8 Hz), 2.65 (sb, 1H), 2.36 (m, 2H), 1.63 (p, 2H, J = 7.3 Hz ), 1.24–1.39 (m, 6H), 0.88 (t, 
3H, J = 6.8 Hz). 
13
C NMR (100 MHz, CDCl3) δ (ppm) 173.4, 136.9, 129.3, 128.3, 126.2, 101.9, 
81.2, 72.8, 71.5, 71.0, 68.7, 67.3, 34.1, 31.4, 28.7, 24.8, 22.4, 14.0; HRMS Calcd for C20H29O6 
[M + H]
+
 365.1964, found 365.1958.  
 
              Compound 8C (30 mg, 21%); white solid; mp 89.0–91.0 °C. 1H NMR (400 MHz, 
CDCl3) δ (ppm) 7.42–7.49 (m, 2H), 7.32–7.40 (m, 3H), 5.51 (s, 1H), 5.01 (t, 1H, J = 9.2 Hz), 
4.35 (dd, 1H, J = 4.9, 10.6 Hz), 4.11 (dd, 1H, J = 5.9, 11.4 Hz), 3.83 (m, 1H), 3.71 (t, 1H, J = 
10.3 Hz), 3.61 (t, 1H, J = 9.3 Hz), 3.44 (dt, 1H, J = 4.9, 9.9 Hz), 3.39 (t, 1H, J = 11.0 Hz), 2.97 
(sb, 1H), 2.41 (t, 2H, J = 7.5 Hz), 1.64 (p, 2H, J = 7.3 Hz), 1.15–1.36 (m, 6H), 0.84 (t, 3H, J = 
6.6 Hz). 
13
C NMR (100 MHz, CDCl3) δ (ppm) 175.7, 137.0, 129.1, 128.2, 126.1, 101.4, 78.4, 
77.1, 71.4, 70.6, 70.1, 68.8, 34.4, 31.4, 28.6, 25.0, 22.4, 14.0; HRMS Calcd for C20H29O6 [M + 
H]
+
 365.1964, found 365.1953.  
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               Compound 9A (14 mg, 8%); white solid; mp 162.0–163.0 °C. 1H NMR (400 MHz, 
CDCl3) δ (ppm) 7.94–8.03 (m, 4H), 7.47–7.55 (m, 2H), 7.35–7.45 (m, 6H), 7.29–7.34 (m, 3H), 
5.83 (t, 1H, J = 9.5 Hz), 5.56 (s, 1H), 5.40 (m, 1H), 4.42 (dd, 1H, J = 4.9, 10.5 Hz), 4.38 (dt, 1H, 
J = 4.8, 9.7 Hz), 3.89 (t, 1H, J = 9.5 Hz), 3.81 (t, 1H, J = 10.3 Hz), 3.61 (t, 1H, J = 9.3 Hz), 3.63 
(dt, 1H, J = 4.9, 9.9 Hz), 3.58 (t, 1H, J = 10.8 Hz). 
13
C NMR (100 MHz, CDCl3) δ (ppm) 165.8, 
165.7, 136.8, 133.4, 133.1, 129.8, 129.76, 129.6, 129.0, 128.5, 128.3, 128.2, 126.1, 101.5, 79.1, 
72.7, 71.7, 70.5, 68.7, 67.7; HRMS Calcd for C27H25O7 [M + H]
+
 460.1600, found 461.1589. 
 
               Compound 9B (26 mg, 19%); white solid; mp 126.0–127.0 °C. 1H NMR (400 MHz, 
CDCl3) δ (ppm) 8.05 (d, 2H, J = 7.1 Hz), 7.60–7.37 (m, 8H), 5.57 (s, 1H), 5.19 (ddd, 1H, J = 
10.6, 9.2, 5.9 Hz), 4.36 (dd, 1H, J = 10.3, 5.0 Hz), 4.26 (dd, 1H, J = 11.0, 5.9 Hz), 4.08 (t, 1H, J 
= 9.2 Hz), 3.75 (t, 1H, J = 10.3 Hz), 3.61 (dd~t, 1H, J = 9.5, 9.2 Hz), 3.45 (m, 2H); 
13
C NMR 
(CDCl3, 100MHz) δ (ppm) 166.0, 136.9, 133.3, 129.7, 129.3, 129.2, 128.4, 128.3, 126.3, 101.8, 
81.1, 72.6, 72.1, 71.0, 68.5, 67.2.  
 
              Compound 9C (45 mg, 32%); white solid; mp 155.0–156.0 °C. 1H NMR (400 MHz, 
CDCl3) δ (ppm) 8.08 (d, 2H, J = 7.7 Hz), 7.58 (m, 1H), 7.41–7.50 (m, 4H), 7.30–7.37 (m, 3H), 
5.56 (s, 1H), 5.30 (t, 1H, J = 9.5 Hz), 4.38 (dd, 1H, J = 4.9, 10.5 Hz), 4.15 (dd, 1H, J = 5.9, 11.4 
Hz), 3.98 (ddd, 1H, J = 5.9, 9.2, 10.5 Hz), 3.72–3.81 (m, 2H), 3.51 (dt, 1H, J = 4.9, 9.5 Hz), 3.46 
(t, 1H, J = 11.0 Hz); 
13
C NMR (100 MHz, CDCl3) δ (ppm) 167.9, 136.9, 133.5, 129.9, 129.4, 
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129.0, 128.4, 128.2, 126.0, 101.4, 78.6, 77.8, 71.4, 70.6, 70.0, 68.8. HRMS Calcd for C20H21O6 
[M + H]
+
 357.1338, found 357.1329.  
 
               Compound 10A (71 mg, 33%); white solid; mp 135.0–137.0 °C. 1H NMR (400 MHz, 
CDCl3) δ (ppm) 8.87 (d, 1H, J = 8.4 Hz), 8.68 (d, 1H, J = 8.4 Hz), 8.26 (m, 1H, J = 7.3 Hz), 8.06 
(d, 1H, J = 7.3 Hz), 8.01 (d, 1H, J = 8.1 Hz), 7.95 (d, 1H, J = 8.1 Hz), 7.79–7.87 (m, 2H), 7.37–
7.57 (m, 8H), 7.31–7.37 (m, 3H), 6.00 (t, 1H, J = 9.5 Hz), 5.63 (s, 1H), 5.60 (m, 1H), 4.47 (m, 
2H), 3.97 (t, 1H, J = 9.5 Hz), 3.85 (t, 1H, J = 10.3 Hz), 3.66–3.75 (m, 2H). 13C NMR (100 MHz, 
CDCl3) δ (ppm) 167.0, 166.2, 136.9, 134.1, 133.7, 133.6, 133.1, 131.4, 131.0, 130.9, 129.4, 
129.0, 128.6, 128.4, 128.2, 128.0, 127.6, 126.3, 126.2, 126.1, 125.54, 125.46, 124.54, 124.48, 
101.5, 79.2, 73.0, 71.8, 70.2, 68.7, 67.9. HRMS Calcd for C35H29O7 [M + H]
+
 561.1913, found 
561.1918.  
 
               Compound 10B (59 mg, 37%); white solid; mp 93.0–95.0 °C. 1H NMR (CDCl3, 
400MHz) δ (ppm) 8.91 (d, 1H, J = 8.8 Hz), 8.21 (d, 1H, J = 7.3 Hz), 8.05 (d, 1H, J = 8.4 Hz), 
7.89 (d, 1H, J = 8.1 Hz), 7.63 (m, 1H), 7.48-7.58 (m, 4H), 7.35–7.43 (m, 3H), 5.58 (s, 1H), 5.30 
(m, 1H), 4.37 (m, 2H), 4.13 (dt, 1H, J = 2.6, 9.2 Hz), 3.76 (t, 1H, J = 10.3 Hz), 3.64 (t, 1H, J = 
9.2 Hz), 3.42–3.54 (m, 2H), 2.83 (d, 1H, J = 2.6Hz). 13C NMR (CDCl3, 100 MHz) δ (ppm) 
166.9, 137.0, 133.8, 133.9, 131.3, 130.5, 129.3, 129.0, 128.4, 128.0, 126.4, 126.3, 125.7, 124.4, 
102.0, 81.3, 72.9, 72.2, 71.1, 68.7, 67.4. HRMS Calcd for C24H23O6 [M + H]+ 407.1495, found 
407.1491.  
 
74 
 
General procedure for acyl chloride synthesis 
           For compound 11, 12, 14, 15, 16, 17, 18, the acyl chlorides were not commercially 
available, so the acids were used to synthesize acyl chloride in situ.  
           For compound 11: 8, 10-heneicosadiynoic acid (166 mg, 5.2 mmol) was mixed with 2 mL 
DCM and cooled in ice bath. 0.1 mL oxalyl chloride (0.1 mL, 12 mmol) was added to mixture 
slowly and the mixture was stirred at room temperature for 2 hours at which time the reaction 
was complete. The solvent was removed under nitrogen and product was used immediately 
following the general procedure of ester synthesis.  
           Compound 11A (20 mg, 6%); white solid; 45.0–47.0 °C. 1H NMR (400 MHz, CDCl3) δ 
7.40–7.45 (m, 2H), 7.32–7.37 (m, 3H), 5.50 (s, 1H), 5.35 (t, 1H, J = 9.5 Hz), 5.05 (ddd-dt, 1H, J 
= 5.9, 9.5, 10.3 Hz), 4.34 (dd, 1H, J = 4.9, 10.5 Hz), 4.12 (dd, 1H, J = 5.9, 11.0 Hz), 3.72 (t, 1H, 
J = 10.3 Hz), 3.63 (t, 1H, J = 9.5 Hz), 3.47 ( dt, 1H, J = 5.1, 9.7 Hz), 3.38 (t, 1H, J = 10.8 Hz), 
2.14–2.37 (m, 12H), 1.58 (m, 4H), 1.41 (m, 8H), 1.38 (m, 4H), 1.26 (sb, 32H), 0.88 (t, 6H, J = 
6.8 Hz). 
13
C NMR (100 MHz, CDCl3) δ (ppm) 172.71, 172.65, 136.8, 129.1, 128.2, 126.1, 101.4, 
78.9, 77.7, 77.6, 77.2, 77.1, 72.1, 71.4, 69.4, 68.6, 67.5, 65.5, 65.4, 65.2, 65.1, 34.2, 33.9, 31.9, 
29.6, 29.5, 29.3, 29.1, 28.9, 28.5, 28.3, 28.1, 28.0, 24.9, 24.6, 22.7, 19.2, 19.1, 14.1. HRMS 
Calcd for C55H80O7Na [M + Na]
+
 875.5802, found 875.5773. 
 
            Compound 11B (70 mg, 33%); white solid; mp 73.0–75.0 °C. 1H NMR (400 MHz, 
CDCl3) δ 7.45–7.52 (m, 2H), 7.33–7.41 (m, 3H), 5.55 (s, 1H), 4.95 (ddd, 1H, J = 5.9, 9.2, 10.6 
Hz), 4.34 (dd, 1H, J = 4.5, 10.5 Hz), 4.12 (dd, 1H, J = 5.9, 11.0 Hz), 3.92 (t, 1H, J = 9.2 Hz), 
3.71 (t, 1H, J = 10.3 Hz ), 3.55 (t, 1H, J = 9.3 Hz), 3.40 ( dt, 1H, J = 4.8, 9.7 Hz), 3.30 (t, 1H, J = 
75 
 
10.8 Hz), 2.29–2.43 (m, 2H), 2.20–2.29 (m, 4H), 1.64 (p, 2H J = 7.3 Hz), 1.51 (m, 4H), 1.32–
1.45 (m, 2H), 1.26 (sb, 16H), 0.88 (t, 3H, J = 6.8 Hz). 
13
C NMR (100 MHz, CDCl3) δ (ppm) 
173.2, 136.9, 129.3, 128.3, 126.2, 101.9, 81.2, 77.7, 77.1, 72.9, 71.5, 71.0, 68.7, 67.3, 65.4, 65.2, 
34.0, 31.9, 29.5, 29.4, 29.3, 29.1, 28.8, 28.5, 28.4, 28.3, 28.1, 24.7, 24.5, 22.7, 19.2, 19.1, 14.1. 
HRMS Calcd for C34H48O6 Na[M + Na]
+
 573.3349, found 575.3344.  
 
              Compound 11C (52 mg, 24%); white solid; mp 58.0–59.0 °C. 1H NMR (400 MHz, 
CDCl3) δ 7.42–7.47 (m, 2H), 7.32–7.39 (m, 3H), 5.51 (s, 1H), 5.02 (t, 1H, J = 9.2 Hz), 4.34 (dd, 
1H, J = 4.9, 10.5 Hz), 4.10 (dd, 1H, J = 5.7, 11.5 Hz), 3.83 (ddd, 1H, J = 5.9, 9.2, 10.6 Hz), 3.70 
(t, 1H, J = 10.3 Hz ), 3.60 (t, 1H, J = 9.5 Hz), 3.44 ( td, 1H, J = 4.8, 9.7 Hz), 3.39 (t, 1H, J = 10.8 
Hz), 2.89 (sbr, 1H), 2.40 (t, 2H, J = 7.3 Hz), 2.24 (t, 2H, J = 7.0 Hz), 2.18 (t, 2H, J = 6.8 Hz), 
1.64 (p, 2H, J = 7.3 Hz), 1.51 (p, 2H, J = 7.3 Hz), 1.19–1.45 (m, 20H), 0.88 (t, 3H, J = 6.8 Hz). 
13
C NMR (100 MHz, CDCl3) δ (ppm) 175.4, 137.0, 129.1, 128.2, 126.1, 101.5, 78.4, 77.7, 77.2, 
77.0, 71.4, 70.6, 70.0, 68.8, 65.4, 65.2, 34.2, 31.8, 29.5, 29.4, 29.3, 29.0 28.8, 28.3, 27.9, 24.8, 
22.6, 19.2, 19.0, 14.1. HRMS Calcd for C34H48O6Na [M + Na]
+
 573.3349, found 575.3336. 
 
             For compound 12: 10,12-tricosadiynoic acid (180 mg, 0.52 mmol) was mixed with 2 mL 
DCM and cooled in ice bath. 0.1 mL oxalyl chloride (0.1 mL, 1.2 mmol) was added to mixture 
slowly and the mixture was stirred at room temperature for 2 hours at which time the reaction 
was complete. The solvent was removed under nitrogen and product was used immediately 
following the general procedure of ester synthesis.  
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              Compound 12A (40 mg, 11%); white solid; mp 55.0–57.0 °C. 1H NMR (400 MHz, 
CDCl3) δ 7.40–7.45 (m, 2H), 7.32–7.37 (m, 3H), 5.50 (s, 1H), 5.35 (t, 1H, J = 9.5 Hz), 5.04 
(ddd-dt, 1H, J = 5.9, 9.9, 10.3 Hz), 4.33 (dd, 1H, J = 4.9, 10.3 Hz), 4.12 (dd, 1H, J = 5.9, 11.0 
Hz), 3.72 (t, 1H, J = 10.3 Hz), 3.63 (dd~t, 1H, J = 9.2, 9.9 Hz), 3.47 ( dt, 1H, J = 5.1, 9.5 Hz), 
3.38 (t, 1H, J = 10.8 Hz), 2.17–2.35 (m, 12H), 1.41–1.61 (m, 12H), 1.14–1.40 (m, 44H), 0.88 (t, 
6H, J = 7.0 Hz). 
13
C NMR (100 MHz, CDCl3) δ (ppm) 172.81, 172.76, 136.9, 129.0, 128.2, 
126.0, 101.4, 78.9, 77.6, 77.4, 72.1, 71.5, 69.4, 68.6, 67.5, 65.3, 65.2, 34.2, 34.0, 31.8, 29.5, 29.4, 
29.3, 29.0, 28.9, 28.8, 28.7, 28.3, 28.2, 25.0, 24.7, 22.6, 19.1, 14.1. HRMS Calcd for 
C59H88O7Na [M + Na]
+
 931.6428, found 931.6392.  
 
             Compound 12B (105 mg, 46%); white solid; mp 88.0–90.0 °C. 1H NMR (400 MHz, 
CDCl3) δ 7.45–7.51 (m, 2H), 7.33–7.41 (m, 3H), 5.55 (s, 1H), 4.95 (ddd, 1H, J = 5.9, 9.2, 10.6 
Hz), 4.33 (dd, 1H, J = 5.1, 10.6 Hz), 4.12 (dd, 1H, J = 5.9, 11.0 Hz), 3.91 (t, 1H, J = 9.2 Hz), 
3.71 (t, 1H, J = 10.3 Hz ), 3.54 (t, 1H, J = 9.2 Hz), 3.40 ( dt, 1H, J = 4.9, 9.7 Hz), 3.30 (t, 1H, J = 
10.8 Hz), 2.29–2.42 (m, 2H), 2.24 (t, 4H, J = 6.8 Hz), 1.63 (m, 2H), 1.52 (p, 4H, J = 7.3 Hz), 
1.17–1.43 (m, 22H), 0.88 (t, 3H, J = 6.8 Hz). 13C NMR (100 MHz, CDCl3) δ (ppm) 172.3, 136.9, 
129.3, 128.3, 126.2, 101.9, 81.2, 77.6, 77.4, 72.8, 71.5, 71.0, 68.6, 67.3, 65.3, 65.2, 34.1, 31.9, 
29.54, 29.46, 29.3, 29.1, 28.9, 28.85, 28.7, 28.32, 28.26, 24.8, 22.7, 19.2, 14.1. HRMS Calcd for 
C36H52O6Na [M + Na]
+
 603.3662, found 603.3657.  
 
            Compound 12C (61 mg, 27%); white solid; mp 41.0–43.0 °C. 1H NMR (400 MHz, 
CDCl3) δ 7.42–7.47 (m, 2H), 7.32–7.38 (m, 3H), 5.50 (s, 1H), 5.03 (t, 1H, J = 9.2 Hz), 4.33 (dd, 
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1H, J = 4.9, 10.5 Hz), 4.09 (dd, 1H, J = 5.7, 11.4 Hz), 3.82 (m, 1H), 3.70 (t, 1H, J = 10.3 Hz ), 
3.59 (t, 1H, J = 9.5 Hz), 3.44 ( td, 1H, J = 4.8, 9.5 Hz), 3.38 (t, 1H, J = 10.8 Hz), 2.40 (t, 2H, J = 
7.5 Hz), 2.16–2.30 (m, 4H), 1.63 (m, 2H), 1.42–1.56 (m, 4H), 1.17–1.43 (m, 22H), 0.88 (t, 3H, J 
= 7.0 Hz). 
13
C NMR (100 MHz, CDCl3) δ (ppm) 175.5, 137.0, 129.1, 128.2, 126.1, 101.4, 78.4, 
77.6, 77.4, 76.9, 71.3, 70.6, 70.0, 68.7, 65.3, 65.2, 34.3, 31.8, 29.5, 29.4, 29.3, 29.0 (2), 28.8, 
28.75, 28.7, 28.3, 28.2, 24.9, 22.6, 19.2, 19.1, 14.1. HRMS Calcd for C36H52O6Na [M + Na]
+ 
603.3662, found 603.3656. 
 
             For compound 14: 4-pentynoic acid (100 mg, 1 mmol) was mixed with 2 mL DCM and 
cooled in ice bath. 0.1 mL oxalyl chloride (0.1 mL, 1.2 mmol) was added to mixture slowly and 
followed by 1 drop anhydrous DMF. The mixture was stirred at room temperature for 2 hours at 
which time the reaction was complete. The solvent was removed under nitrogen and product was 
used immediately following the general procedure of ester synthesis.  
 
             Compound 14A (31 mg, 30%); light yellow solid; mp 115.0-116.0°C. 
1
H NMR (400 
MHz, CDCl3) δ 7.49 – 7.39 (m, 2H), 7.34 (ddd, J = 20.8, 11.2, 5.5, 4H), 7.08 (t, J = 7.4, 2H), 
6.99 (d, J = 7.8, 2H), 5.53 (s, 1H), 5.45 (t, J = 9.4, 1H), 5.36 – 5.29 (m, 1H), 5.20 (d, J = 7.7, 
1H), 4.42 (dd, J = 10.6, 4.9, 1H), 3.84 (dd, J = 19.3, 9.8, 2H), 3.68 (td, J = 9.7, 4.9, 1H), 2.66 – 
2.37 (m, 8H), 1.91 (dt, J = 10.0, 2.5, 2H). 
13
C NMR (101 MHz, CDCl3) δ 170.8, 170.3, 136.6, 
129.6, 129.2, 128.2, 126.2, 123.5, 117.0, 101.6, 99.6, 82.2, 78.1, 72.2, 71.8, 69.3, 69.2, 68.5, 
66.6, 33.2, 33.1, 14.3, 14.2. HRMS Calcd for C29H29O8 [M + H]
+
 505.1862, found 505.1865.  
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              Compound 14B (39 mg, 45% ); white solid; mp 54.0-55.0 °C  
1
H NMR (400 MHz, 
CDCl3) δ 7.45 (dd, J = 6.7, 2.9, 2H), 7.41 – 7.28 (m, 5H), 7.14 – 6.99 (m, 3H), 5.52 (s, 1H), 5.35 
(t, J = 9.4, 1H), 5.11 (d, J = 7.6, 1H), 4.39 (dd, J = 10.5, 4.8, 1H), 3.94 – 3.71 (m, 3H), 3.66 (td, J 
= 9.7, 4.9, 1H), 2.67 (dd, J = 11.2, 4.2, 2H), 2.54 (ddd, J = 9.4, 5.8, 2.2, 2H), 1.91 (t, J = 2.6, 
1H). 
13
C NMR (101 MHz, CDCl3) δ 171.6, 156.8, 136.8, 129.7, 129.2, 128.3, 126.2, 123.4, 
117.0, 101.6, 101.5, 82.3, 78.1, 73.9, 73.1, 69.2, 68.6, 66.6, 33.4, 14.5. HRMS Calcd for 
C24H24O7Na [M + Na]
+
 447.1420, found 447.1418. 
 
             For compound 15: 5-hexynoic acid (0.11 mL, 1 mmol) was mixed with 2 mL DCM and 
cooled in ice bath. 0.1 mL oxalyl chloride (0.1 mL, 1.2 mmol) was added to mixture slowly and 
followed by 1 drop anhydrous DMF. The mixture was stirred at room temperature for 2 hours at 
which time the reaction was complete. The solvent was removed under nitrogen and product was 
used immediately following the general procedure of ester synthesis.  
 
             Compound 15A (22 mg, 20%); white solid; mp 68.0-70.0 °C. 
 1
H NMR (400 MHz, 
CDCl3) δ 7.44 (dd, J = 6.5, 2.9, 2H), 7.40 – 7.27 (m, 5H), 7.08 (t, J = 7.4, 1H), 7.00 (d, J = 7.9, 
2H), 5.54 (s, 1H), 5.43 (t, J = 9.4, 1H), 5.34 – 5.28 (m, 1H), 5.19 (d, J = 7.7, 1H), 4.42 (dd, J = 
10.5, 4.9, 1H), 3.90 – 3.77 (m, 2H), 3.67 (td, J = 9.6, 4.9, 1H), 2.53 – 2.41 (m, 4H), 2.23 (ddd, J 
= 15.7, 7.1, 2.6, 4H), 1.96 (t, J = 7.3, 1H), 1.88 – 1.76 (m, 5H). 13C NMR (101 MHz, CDCl3) δ 
172.1, 171.6, 156.8, 136.6, 129.7, 129.2, 128.3, 126.1, 123.4, 117.0, 101.6, 99.8, 83.0, 82.9, 78.2, 
72.0, 71.6, 69.3, 69.2, 68.5, 66.6, 32.7, 32.6, 23.6, 23.5, 17.7, 17.6. HRMS Calcd for 
C31H32O8Na [M + Na]
+
 555.1995, found 555.1992. 
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            Compound 15B (56 mg, 63%); white solid; mp 128.0-129.0°C. 
1
H NMR (400 MHz, 
CDCl3) δ 7.45 (dd, J = 6.5, 2.9, 2H), 7.40 – 7.28 (m, 5H), 7.08 (dd, J = 14.9, 7.6, 3H), 5.53 (s, 
1H), 5.33 (t, J = 9.4, 1H), 5.10 (d, J = 7.6, 1H), 4.39 (dd, J = 10.5, 4.8, 1H), 3.94 – 3.72 (m, 3H), 
3.65 (td, J = 9.6, 4.9, 1H), 2.65 – 2.52 (m, 2H), 2.26 (td, J = 6.9, 2.6, 1H), 2.02 – 1.79 (m, 3H). 
13
C NMR (101 MHz, CDCl3) δ 173.1, 156.8, 136.8, 129.7, 129.1, 128.3, 126.1, 123.4, 117.0, 
101.6, 101.6, 83.2, 78.2, 73.5, 73.3, 69.2, 68.6, 66.6, 32.9, 23.7, 17.6. 
 
            For compound 16: 6-heptynoic acid (0.16 mL, 1.2 mmol) was mixed with 2 mL DCM 
and cooled in ice bath. 0.1 mL oxalyl chloride (0.1 mL, 1.2 mmol) was added to mixture slowly 
and followed by 1 drop anhydrous DMF. The mixture was stirred at room temperature for 2 
hours at which time the reaction was complete. The solvent was removed under nitrogen and 
product was used immediately following the general procedure of ester synthesis.  
 
             Compound 16A (43 mg, 30%); white solid; mp 92.0-93.0 °C. 
 1
H NMR (400 MHz, 
CDCl3) δ 7.44 (dd, J = 6.7, 2.7, 2H), 7.40 – 7.28 (m, 5H), 7.08 (t, J = 7.4, 1H), 7.02 – 6.96 (m, 
2H), 5.54 (s, 1H), 5.43 (t, J = 9.4, 1H), 5.31 (t, J = 8.5, 1H), 5.20 (d, J = 7.7, 1H), 4.42 (dd, J = 
10.5, 4.9, 1H), 3.83 (dd, J = 22.0, 9.9, 2H), 3.68 (td, J = 9.7, 4.9, 1H), 2.43 – 2.27 (m, 4H), 2.14 
(dtd, J = 9.6, 7.0, 2.6, 4H), 1.96 – 1.88 (m, 2H), 1.79 – 1.64 (m, 4H), 1.51 (dq, J = 14.2, 7.2, 4H). 
13
C NMR (101 MHz, CDCl3) δ 172.5, 171.9, 156.8, 136.7, 129.7, 129.2, 128.3, 126.1, 123.4, 
116.8, 101.6, 99.7, 83.8, 83.7, 78.2, 71.9, 71.5, 68.7, 68.6, 68.5, 66.6, 33.6, 33.5, 27.6, 27.5, 23.9, 
23.8, 18.1, 18.0. HRMS Calcd for C33H37O8 [M + H]
+
 561.2488, found 561.2491.  
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              Compound 16B (49 mg, 42%); white solid; mp 127.0-129.0 °C. 
1
H NMR (400 MHz, 
CDCl3) δ 7.45 (dd, J = 6.5, 3.0, 2H), 7.41 – 7.29 (m, 5H), 7.08 (dd, J = 15.1, 7.6, 3H), 5.52 (s, 
1H), 5.33 (t, J = 9.4, 1H), 5.10 (d, J = 7.6, 1H), 4.37 (dt, J = 27.3, 13.7, 1H), 3.94 – 3.70 (m, 3H), 
3.65 (td, J = 9.6, 4.9, 1H), 2.44 (t, J = 7.3, 2H), 2.14 (td, J = 7.0, 2.6, 2H), 1.93 (t, J = 2.6, 1H), 
1.78 (tt, J = 13.3, 6.6, 2H), 1.65 – 1.47 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 173.5, 156.8, 
136.8, 129.7, 129.2, 128.3, 126.1, 123.4, 117.0, 101.6, 101.6, 84.0, 78.2, 73.4, 73.2, 68.6, 68.5, 
66.6, 33.7, 27.4, 24.0, 18.0. HRMS Calcd for C26H29O7 [M + H]
+
 453.1913, found 453.1913. 
HRMS Calcd for C25H27O7 [M + H]
+
 439.1757, found 439.1761. 
 
             For compound 17: 10,12-tricosadiynoic acid (282 mg, 0.8 mmol) was mixed with 2 mL 
DCM and cooled in ice bath. 0.1 mL oxalyl chloride (0.09 mL, 1.0 mmol) was added to mixture 
slowly and followed by 1 drop anhydrous DMF. The mixture was stirred at room temperature for 
2 hours at which time the reaction was complete. The solvent was removed under nitrogen and 
product was used immediately following the general procedure of ester synthesis.  
 
             Compound 17A (11 mg, 5%); white solid; mp 41.0-43.0 °C.
 1
H NMR (400 MHz, CDCl3) 
δ 7.44 (dd, J = 6.6, 3.0, 3H), 7.39 – 7.34 (m, 3H), 7.33 – 7.27 (m, 1H), 7.08 (t, J = 7.4, 1H), 6.99 
(d, J = 7.8, 2H), 5.51 (s, 1H), 5.43 (t, J = 9.4, 1H), 5.33 – 5.27 (m, 1H), 5.20 (d, J = 7.7, 1H), 
4.50 – 4.33 (m, 1H), 3.93 – 3.76 (m, 2H), 3.67 (tt, J = 13.0, 6.4, 1H), 2.50 – 2.10 (m, 8H), 1.81 – 
0.51 (m, 64H), 0.88 (t, J = 6.8, 10H).
 13
C NMR (101 MHz, CDCl3) δ 172.8, 172.2, 156.8, 136.7, 
129.6, 129.1, 128.2, 126.1, 123.3, 116.8, 101.5, 99.7, 78.3, 77.6, 77.4, 71.7, 71.4, 68.6, 66.6, 
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65.3, 65.2, 34.2, 34.1, 31.9, 29.7, 29.6, 29.5, 29.3, 29.1, 29.0, 28.9, 28.8, 28.4, 28.3, 25.0, 24.9, 
24.7, 22.7, 19.2, 14.1. HRMS Calcd for C69H100O8Na [M + Na]
+
 1079.7316, found 1079.7306. 
 
              Compound 17B (90 mg, 63%); white solid; mp 49.0-51.0 °C.
 1
H NMR (400 MHz, 
CDCl3) δ 7.45 (dd, J = 6.3, 3.0, 2H), 7.34 (ddd, J = 16.1, 6.9, 2.2, 6H), 7.12 – 7.03 (m, 2H), 5.53 
(s, 1H), 5.31 (t, J = 9.4, 1H), 5.11 (d, J = 7.6, 1H), 4.38 (dt, J = 12.1, 6.1, 1H), 3.81 (ddd, J = 
29.2, 17.9, 8.7, 3H), 3.65 (td, J = 9.6, 4.7, 1H), 2.46 – 2.37 (m, 2H), 2.23 (dd, J = 16.1, 7.5, 7H), 
1.73 – 1.01 (m, 25H), 0.88 (t, J = 6.8, 7H). 13C NMR (101 MHz, CDCl3) δ 174.0, 156.8, 136.8, 
129.7, 129.1, 128.2, 126.1, 123.4, 117.0, 101.7, 101.5, 78.2, 77.6, 77.5, 73.5, 73.3, 68.6, 66.7, 
65.3, 65.2, 34.3, 31.9, 29.8, 29.7, 29.6, 29.5, 29.3, 29.1, 29.0, 28.9, 28.8, 28.7, 28.4, 28.3, 25.0, 
24.7, 22.7, 19.2, 19.1, 14.1. HRMS Calcd for C44H61O7 [M + H]
+
 701.4417, found 701.4423.  
 
               For compound 18: 10,12-pentacosadiynoic acid (260 mg, 0.7 mmol) was mixed with 2 
mL DCM and cooled in ice bath. 0.1 mL oxalyl chloride (0.09 mL, 1.0 mmol) was added to 
mixture slowly and followed by 1 drop anhydrous DMF. The mixture was stirred at room 
temperature for 2 hours at which time the reaction was complete. The solvent was removed 
under nitrogen and product was used immediately following the general procedure of ester 
synthesis.  
 
              Compound 18A (9 mg, 4%); white solid; mp 56.0-58.0 °C .
 1
H NMR (400 MHz, CDCl3) 
δ 7.48 – 7.40 (m, 2H), 7.39 – 7.27 (m, 5H), 7.08 (t, J = 7.4, 1H), 6.99 (d, J = 8.4, 2H), 5.53 (s, 
1H), 5.43 (t, J = 9.4, 1H), 5.34 – 5.27 (m, 1H), 5.20 (d, J = 7.7, 1H), 4.40 (dt, J = 13.9, 7.0, 1H), 
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3.90 – 3.76 (m, 2H), 3.67 (ddd, J = 18.3, 11.6, 6.7, 1H), 2.37 – 2.16 (m, 14H), 1.70 – 1.11 (m, 
54H), 0.88 (t, J = 6.8, 8H).
 13
C NMR (101 MHz, CDCl3) δ 172.8, 172.2, 156.8, 136.7, 129.6, 
129.1, 128.2, 126.1, 123.3, 116.8, 101.5, 99.7, 78.3, 77.6, 77.4, 71.7, 71.3, 68.5, 66.6, 65.3, 65.2, 
34.2, 34.1, 31.9, 29.6, 29.5, 29.3, 29.1, 29.0, 28.9, 28.8, 28.7, 28.4, 28.3, 25.0, 24.9, 22.7, 19.2, 
19.1, 14.1. HRMS Calcd for C65H92O8 [M + H]
+
 1001.6870, found 1001.6871.  
 
              Compound 18B (89 mg, 65%); white solid; mp 39.0-40.0 °C. 
1
H NMR (400 MHz, 
CDCl3) δ 7.44 (dd, J = 6.5, 2.9, 2H), 7.39 – 7.28 (m, 5H), 7.08 (dd, J = 12.1, 7.6, 3H), 5.53 (s, 
1H), 5.31 (t, J = 9.4, 1H), 5.11 (d, J = 7.6, 1H), 4.39 (dd, J = 10.5, 4.8, 1H), 3.91 – 3.71 (m, 3H), 
3.65 (td, J = 9.7, 4.9, 1H), 2.47 – 2.14 (m, 5H), 1.79 – 1.00 (m, 27H), 0.88 (t, J = 6.8, 4H). 13C 
NMR (101 MHz, CDCl3) δ 174.0, 156.8, 136.8, 129.7, 129.2, 128.2, 126.1, 123.4, 117.0, 101.7, 
101.5, 78.2, 77.6, 73.5, 73.4, 68.6, 66.7, 65.3, 65.2, 34.3, 31.9, 29.6, 29.5, 29.3, 29.1, 29.0, 28.9, 
28.8, 28.7, 28.4, 28.3, 25.0, 24.7, 22.7, 19.2, 14.1. HRMS Calcd for C42H57O7 [M + H]
+
 
673.4104, found 673.4105. 
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                                                            Chapter III  
 
Synthesis and Characterization of Unprotected D-Glucosamine Based Low Molecular 
Weight Gelators. 
 
Abstract: Glucosamine is an amino sugar present in animal bones, bone marrow, cell walls of 
fungi and many higher organisms. The amino group of 2-glucosamine allows the molecule to be 
functionalized with different functional groups. Our group has utilized the 4,6-benzylidene acteal 
protected D-glucosamine 1 as a template and synthesized various amide, urea and carbamate 
derivatives. Many of the derivatives were found to be efficient gelators for aqueous DMSO and 
aqueous ethanol solutions, and only a few of them can form gel in water. For biological 
applications, hydrogelators are more advantageous than organogelators.  In this chapter, there are 
two main goals. The first goal is to find out the importance of the benzylidene acetal group by 
using compound 2 as the template for the synthesis of potential gelators; the second main goal is 
to synthesize and evaluate whether the unprotected D-glucosamine 3 derivatives can serve as 
efficient low molecular weight hygrogelators.  
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                                                            Introduction 
Glucosamine and N-acetyl glucosamine are naturally present in many organisms. 
Chitosan is partially made by glucosamine. Chitin is a polymer of N-acetyl glucosamine. The 
structure of chitin is shown in compound 4.
1 
Glucosamine is widely used as a dietary supplement 
for supporting function and structure of joints. It is also used to relieve osteoarthritis. The 
medicinal effect of glucosamine may be anti-inflammatory. 
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4  
 
The glucosamine derivatives have been studied in different research areas.
2-20
 
Glucosamines were attached to carboxylic acids which were associated with nanotubes.
21
 The 
resulting nanotubes can dissolve in water from 0.1 mg/mL to 0.3 mg/mL. South Korean 
researchers synthesized copper-glucosamine microcubes to study biofunctionalized 
microstructure electrodes.
22
  
 
           In gelator area, derivatives of glucosamine have been studied along with other sugars. Due 
to the natural abundance, the polymer form of glucosamine chitin was one of the first materials 
to be tested. Chitin is a very good gelator which can form gel under mild condition.
[1]
 For 
glucosamine based low molecular weight gelators, Pavel Drasar research group studies amides 
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formed by steroid and bile acids with D-glucosamine.
23
 The gelation tests showed negative 
results. Bin Xu research group linked D-glucosamine with L/D-phenylalanine and naphthyl 
group.  The resulting two compounds can form gel in water at 2 mg/mL. The structures of two 
compounds are shown below.
24 
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                                    Figure 3.1 Structures of glucosamine based hydrogelators 
 
             Bing Xu, etc also examined the biocompatibility of the two gels. In cytotoxicity assay, 
compound 5 showed 73.8% Hela cell survival in 100 µM in 24 hours. The compound 6 showed 
79.0% at the same condition. Based on the above results, compound 6 was used in wound 
healing test on mouse model. In the comparison with controlled group, mice treated with gel 
showed much faster healing and smaller scar.   
 
            Our group has been studying derivatives of D-glucosamine including carbamates, amides, 
and ureas as low molecular weight gelators Using the 4, 6-benzylidene acetal protected 
headgroup 1 as the starting material, ureas 7 and amides 8 have been synthesized and evaluated. 
The glucosamine head group reacted with acyl chloride, isocyanate, chloroformate to form 
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amides, ureas, carbamates. The R group included straight chain alkyl, terminal alkyne, aromatic 
rings.
25 
                              
                           Figure 3.2 The common structures of urea and amide 
 
            All the products of amide and urea can form gels in DMSO: H2O (1:2), EtOH: H2O (1:2). 
The hexyl urea, heptyl urea and heptyl amide formed gel at 1 mg/mL in DMSO water mixture. 
Phenyl amide gelled water at 2 mg/mL. When we compare these results with results of esters 
from the first chapter, we can conclude that amides and ureas are much better. The glucosamine 
derivatives contain extra hydrogen bonding groups, the NH groups.  
 
             In the previous chapter, we systemically studied the effect of different group at anomeric 
position. Now we switch our attention to the 4, 6 position. Benzylidene was widely used as the 
protecting group as we can see from Chapter 1 and compound 1. The phenyl ring provides the π-
π stacking in gelation process. Other functional groups at the 4, 6 position were not fully studied,   
so we want to study the structure and gelation relationship by changing the protecting group to 
isopropylidene and no protecting group. 
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             Another reason for this research is when it comes to biological applications, low 
molecular weight hydrogelators are more favored. To synthesize more hydrogelators, we 
hypothesized that by removing the 4, 6-protective groups after introducing functional groups at 
2, 3-positions, and the polarity changes significantly.  
  
            To synthesize these, we can deprotect the benzylidene acetal directly; however, the 
byproduct benzaldehyde was not easily removed. Phase-phase extraction was used and 
benzaldehyde was in organic phase. However to obtain the product we have to remove water and 
in some situation compounds with aromatic functional group can also dissolve in organic phase. 
To simplify workup, we decided to replace benzyl with isopropyl. Then the byproduct was 
acetone and in this case no workup or purification was needed.                                                    
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                                                         Results and Discussion 
             Head group 2 was synthesized in three steps from N-acetyl D-glucosamine 9.  Treatment 
of 6 with methanol in the presence of acidic ion exchange resin gave the methyl glycoside 10 in 
91% yield. Protection of the 4- and 6- hydroxyl groups of 7 with 2, 2-dimethoxy propane 
afforded the acetal-protected analog 11 in 90% yield.  Head group 2 was then obtained by 
deprotecting the 2-amino group under basic conditions, which took place in 85% yield. 
      
               Scheme 3.1 The synthesis of 4, 6-O-isopropylidene-methyl-D-glucosamine. 
 
With head group 2 in hand, amides derivatives with the general structure 12 were 
synthesized by reacting head group 2 with various acyl chlorides in the presence of pyridine. 
Ureas with the general structure 14 were made by reacting head group 2 with various 
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isocyanates. The selection of acyl chlorides and isocyanates were based on the availability of 
starting materials and our previous studies of ureas and amides with the general structures 7 and 
8.  For the amides, we synthesized the 5 and 10 carbon chain terminal alkynoyl, 6, 10, and 22 
carbon chain saturated alkanoyl, benzoyl and naphthoyl derivatives. Yields ranged from 76-95%. 
The acyl chloride of 17, 18, 22 were synthesized in situ. For the ureas, the undecynyl, octanoyl, 
dodecanyl, phenyl, naphthyl, and cyclohexyl derivatives were synthesized, in 65-92% yield. The 
isocyanate of 27, 28 were synthesized through Curtius rearrangement. The amides and ureas 
yields and gel tests results are shown in Table 3.1, 3.2, 3.3, 3.4. 
O
O
HO
NH
O
OCH3O
R
16 18
19 20
17
20
21 22
12
 
                                           Table 3.1 Yields of amides 
Compound 16 17 18 19 20 21 22 
  Yield 96 % 76 % 75 % 95 % 69 % 85 % 83 % 
 
 
 
 
92 
 
Table 3.2 Library of amide derivatives of 12 and their corresponding minimum gelation 
concentrations (MGCs) in mg/mL.  
Compound Hexane H2O EtOH EtOH:H2O (1:2) DMSO:H2O (1:2) 
16 P S S S S 
17 I S S P P 
18 P I S I I 
19 P S S S S 
20 I P S S S 
21 I P S P P 
22 I P S P P 
 
All concentrations are in mg/mL; G, gel at room temperature; the numbers after G are minimum 
gelation concentrations; P, precipitation; S, soluble at~20 mg/mL; the ratios of solvents are in 
parenthesis. 
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                                                       Table 3.3 Yields of Ureas 
Compound 23 24 25 26 27 28 
Yield 96 % 76 % 75 % 95 % 69 % 85 % 
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Table 3.4 Library of urea derivatives of 9 and their corresponding minimum gelation 
concentrations (MGCs) in mg/mL.  
Compound Hexane H2O EtOH EtOH:H2O (1:2) DMSO:H2O (1:2) 
23 I P S P G 20 
24 I P S S S 
25 I P S P G 20 
26 I P S P P 
27 I P S P P 
28 I P S P P 
 
All concentrations are in mg/mL; G, gel at room temperature; the numbers after G are minimum 
gelation concentrations; P, precipitation; S, soluble at~20 mg/mL; the ratio of solvents in 
parenthesis. 
 
              Unfortunately, none of the amides were able to form gels in any of the 5 solvents. This 
is not completely unexpected; we knew that replacing the benzylidene acetal group with an 
isopropylidene acetal would eliminate the possibility for intermolecular π-π stacking interactions 
among the molecules, which can help contribute to gel formation.   Among the ureas, two of the 
compounds, the benzyl and naphthyl derivatives, were able to form gels in aqueous DMSO at 
concentrations of 20 mg/mL.  It seems that the phenyl and naphthyl rings provide an alternative 
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π-π stacking group, which is essential for gelation. However, the gelation efficiency is not as 
good as the phenyl and naphthyl ureas of 4, 6-O-benzylidene-methyl-α-D-glucosamine with the 
general structure 7.      
 
             The amides and ureas were treated with 85% acetic acid and stirred at room temperature 
for around 6 hours to remove the isopropylidene acetal functionality. After the reaction was 
done, the excess acetic acid and acetone byproduct were removed by evaporation under a stream 
of nitrogen, without need for further purification. The deprotected products (13, 15) were then 
screened for gelation in water, hexane, ethanol, and aqueous mixtures of ethanol and DMSO; the 
yields and gel tests results are shown in Table 3.5, 3.6, 3.7, 3.8. 
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                                          Table 3.5 Yields of deprotected amides 
Compound 29 30 31 32 33 34 35 
Yield 96 % 96 % 90 % 97 % 95 % 95 % 95 % 
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Table 3.6 Library of amide derivatives of 23 and their corresponding minimum gelation 
concentrations (MGCs) in mg/mL.     
Compound Hexane H2O EtOH EtOH:H2O(1:2) DMSO:H2O(1:2) 
29 I S S S S 
30 I S S S S 
31 P I G 9 G 8 G 5 
32 I P G 10 S S 
33 I P P S S 
34 I P S P P 
35 I G 20 S G 20 G 10 
 
All concentrations are in mg/mL; G, gel at room temperature; the numbers after G are minimum 
gelation concentrations; P, precipitation; S, soluble at~20 mg/mL; the ratio of solvents in 
parenthesis. 
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                                              Table 3.7 Yields of deprotected ureas 
Compound 36 37 38 39 40 41 
Yield 96 % 96 % 95 % 94 % 95 % 95 % 
 
 
Table 3.8 Library of urea derivatives of 24 and their corresponding minimum gelation 
concentrations (MGCs) in mg/mL.                   
Compound Hexane H2O EtOH EtOH:H2O (1:2) DMSO:H2O (1:2) 
36 I P S S S 
37 I P P P P 
38 I G 4 S G 20 G 4 
39 I P S G 20 G 20 
40 I G 3 S G 7 G 7 
41 I I G 10 G 7 P 
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All concentrations are in mg/mL; G, gel at room temperature; the numbers after G are minimum 
gelation concentrations; P, precipitation; S, soluble at~20 mg/mL; the ratios of solvents are in 
parenthesis. 
 
             Figure 3.3a shows the hydrogel of 40 at 2.5 mg/mL. The picture shows some liquid 
comes from the top. So the minimum concentration is greater than 2.5 mg/mL, at 3 mg/mL the 
gel was stable.  Therefore the safe estimate of the MIC is 3 mg/mL.  
                                 
Figure 3.3 a) A photograph of a gel formed by compound 40 in water at 2.5 mg/mL. b) A 
photograph of a gel formed by compound 41 in DMSO: H2O (1:2) at 7 mg/mL.  
 
           For amide derivatives, after the removal of isopropyl group at 4, 6-position, gelation 
properties improved significantly. Three compounds formed gel in different solvents. The 22 
carbon chain amide 39 was the best one. It can gel 9 mg/mL in ethanol, 8 mg/mL in 33% 
aqueous solution of DMSO and 5 mg/mL in 33% aqueous solution of ethanol. The 10 carbons 
terminal acetylene amide 40 can gel in 33% aqueous solution of DMSO or ethanol. It also gelled 
water at 20 mg/mL. The phenyl amide only forms gel in ethanol at 10 mg/mL. Naphthal amide 
does not form any gel. Compare with the amides before deprotection, the molecules have two 
more hydroxy groups which make them more polar and hydrophilic. The main driving force after 
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deprotection is the balance between hydrophobic and hydrophilic interaction not the π-π 
stacking. The deprotected amides behaving well all have very long carbon chains which make 
the molecules hydrophobic. At the same time 33% aqueous DMSO or ethanol gives the right 
amount of water. 
 
             For urea derivatives, four compounds form gel in different solvents. Compare with the 
urea derivatives before deprotection, which only two compounds gel in one solvents, the gelation 
property improve dramatically. Naphthal urea 38 and 10 carbon terminal acetylene urea 40 gel in 
water, 33% aqueous DMSO or ethanol.  They gel water at 4mg/mL and 3 mg/mL, which are very 
good hydrogelators. 22 carbons urea 41 gels ethanol at 10mg/mL and 33% aqueous DMSO at 7 
mg/mL. The improved gelation property is mainly due to the balance of hydrophobic and 
hydrophilic interaction. Four compounds all have long carbon chain or aromatic ring system, 
after the introduction of two new hydroxyl groups, the molecules are balanced.  
 
           Comparing deprotected ureas and deprotected amides, the deprotected ureas performed  
better than deprotected amides. This result is consistent with our previous results using different 
head groups. The urea derivatives have more hydrogen bond donor than amide derivatives.  
 
           Some of images from optical microscope are shown in Figures 3.4-3.6. The gel formed by 
compound 30 consisted of thin fibers, as shown in Figure 3.3. The very bright area indicated that 
lots of fibers packed there. The morphology of compound 35 was quite different from others. It 
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seemed that fibers all connected with each other and formed a big piece of sheet. The gel pictures 
of compound 37 were taken at 3 mg/mL and we can see the small tubes instead of long fibers.  
 
 
                                 
Figure 3.4 500x Optical micrographs of gel formed by compound 30 at 10 mg/mL in EtOH: H2O 
(1: 2).   
 
               
Figure 3.5 500x Optical micrographs of gel formed by compound 35 at 20 mg/mL in 
DMSO:H2O (1:2).  
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Figure 3.6 Optical micrographs of a gel formed by compound 37 at 3 mg/mL in water, the left 
was at 200x magnification, and the right was 500x magnification.  
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                                                               Conclusions 
             Amide and urea series of 4, 6-O-isopropylidene-Methyl-α-D-glucsamine has been 
synthesized through straight reactions with high yields. The gelation property has been tested in 
5 different solvent. Compare the results of amides and ureas using 4, 6-O -benzylidene-methyl-α-
D-glucosamine head group, we found that the π-π stacking from phenyl ring can significantly 
affect the gelation. Amide and urea series of methyl-α-D-glucosamine were synthesized after 
acid removal of isopropyl group. The gelation property changed dramatically especially for 
ureas. Naphthyl urea 38 and other three long alkyl chain ureas 39, 40, 41 formed gel in 
DMSO:H2O (1:2), EtOH:H2O (1:2), water. Urea 40 gelled water at 3 mg/mL. These compounds 
shared some common features like long straight carbon chain which can contribute to the balance 
between hydrophobicity and hydrophilicity.  
 
 
 
 
 
 
 
 
                          
104 
 
                                                   Experimental section 
General procedure for the synthesis of amide 
             4,6-O-Isopropylidene-Methyl-α-D-Glucosamine (50 mg, 0.214 mmol) was dissolved in 
anhydrous THF with pyridine (1.07 mmol). The corresponding acyl chloride (0.214mmol) was 
added to the solution, which was then stirred at room temperature for 8 hours. The reaction 
mixture was worked up by DCM extraction. The crude product can be purified by flash 
chromatography on silica gel using the solvent system hexane and ethyl acetate. 
 
            Compound 16 (109 mg, 96%); white solid; mp 107.0-108.5 °C. 
1
H NMR (400 MHz, 
CDCl3) δ 5.92 (d, J = 8.6, 1H), 4.66 (d, J = 3.8, 1H), 4.13 (td, J = 9.3, 3.8, 1H), 3.84 (dd, J = 
10.6, 4.5, 1H), 3.79 – 3.65 (m, 2H), 3.65 – 3.52 (m, 2H), 3.34 (s, 3H), 2.21 (t, J=7.3, 2H), 1.61 
(quintet, J=7.3, 2H), 1.50 (s, 3H), 1.41 (s, 3H), 1.38 – 1.21 (m, 5H), 0.87 (t, J = 6.8, 3H). 13C 
NMR (101 MHz, CDCl3) δ 174.9, 100.0, 99.0, 77.6, 77.2, 76.9, 74.9, 71.2, 63.4, 62.4, 55.3, 54.3, 
36.7, 31.5, 29.3, 25.4, 22.5, 19.2, 14.1. 
 
            For compound 17: 5-hexynoic acid (46 mg, 0.4 mmol) was mixed with 2 mL DCM and 
cooled in ice bath. 0.1 mL oxalyl chloride (0.07 mL, 0.8 mmol) was added to mixture slowly and 
the mixture was stirred at room temperature for 2 hours at which time the reaction was complete. 
The solvent was removed under nitrogen and product was used immediately following the 
general procedure of amide synthesis.  
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            Compound 17 (86 mg, 76%); white solid; Compound is extremely hygroscopic, and 
absorbs moisture to become gummy oil within a few minutes.  Thus, melting point could not be 
obtained.  
1
H NMR (400 MHz, CDCl3) δ 5.98 (d, J = 8.7, 1H), 4.66 (d, J = 3.8, 1H), 4.15 (td, J = 
9.4, 3.8, 1H), 3.84 (dd, J = 10.6, 4.5, 1H), 3.80 – 3.66 (m, 2H), 3.66 – 3.53 (m, 2H), 3.38 (s, 3H), 
2.38 (t, J = 7.3, 2H), 2.29-2.23 (m, 2H), 1.98 (t, J = 2.6, 1H), 1.92 – 1.80 (m, 2H), 1.51 (s, 3H), 
1.42 (s, 3H).  
13
C NMR (101 MHz, CDCl3) δ 173.8, 100.0, 99.0, 83.6, 74.9, 71.1, 69.5, 63.5, 
62.4, 55.9, 55.4, 54.3, 35.1, 29.3, 24.1, 19.3, 17.8. 
 
             For compound 18:10-undecynoic acid (66 mg, 0.4 mmol) was mixed with 2 mL DCM 
and cooled in ice bath. 0.1 mL oxalyl chloride (0.07 mL, 0.8 mmol) was added to mixture slowly 
and the mixture was stirred at room temperature for 2 hours at which time the reaction was 
complete. The solvent was removed under nitrogen and product was used immediately following 
the general procedure of amide synthesis.  
 
             Compound 18 (144 mg, 75%); white solid; mp 97.0-98.0 °C.  
1
H NMR (400 MHz, 
CDCl3) δ 5.88 (d, J = 8.5, 1H), 4.66 (d, J = 3.8, 1H), 4.15 (td, J = 9.3, 3.8, 1H), 3.85 (dd, J = 
10.7, 4.3, 1H), 3.80 – 3.65 (m, 2H), 3.65 – 3.52 (m, 2H), 3.35 (s, 3H), 3.20 (s, 1H), 2.22 (t, J = 
7.5, 2H), 1.61 (dd, J = 13.9, 6.9, 2H), 1.52 (s, 3H), 1.42 (s, 3H), 1.24 (s, 36H), 0.86 (t, J = 6.7, 
3H).  
13
C NMR (101 MHz, CDCl3) δ 175.0, 100.0, 99.0, 74.9, 71.4, 63.4, 62.4, 55.3, 54.3, 36.8, 
32.1, 29.9, 29.8, 29.8, 29.7, 29.5, 29.4, 29.3, 25.8, 22.9, 19.3, 14.3.  
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              Compound 19 (119 mg, 95%); white solid; mp 74.5-76 °C. 
1
H NMR (400 MHz, CDCl3) 
δ 7.77 (d, J = 7.3, 2H), 7.48 (t, J = 7.4, 1H), 7.40 (t, J = 7.5, 2H), 6.59 (d, J = 8.6, 1H), 4.79 (d, J 
= 3.8, 1H), 4.37 (td, J = 9.3, 3.8, 1H), 3.94 – 3.73 (m, 3H), 3.70 – 3.59 (m, 2H), 3.38 (s, 3H), 
1.52 (s, 3H), 1.43 (s, 3H).  
13
C NMR (101 MHz, CDCl3) δ 168.7, 133.9, 132.0, 128.7, 127.4, 
100.1, 99.1, 74.9, 71.1, 63.5, 62.4, 55.4, 54.8, 29.3, 19.3. 
 
              Compound 20 (92 mg, 69%); white solid; mp 198.0-199.0 °C. 
1
H NMR (400 MHz, 
CDCl3) δ 8.26 – 8.16 (m, 1H), 7.82 – 7.71 (m, 2H), 7.52 (dd, J = 7.0, 1.0, 1H), 7.45 – 7.38 (m, 
2H), 7.32 – 7.27 (m, 1H), 6.36 (d, J = 8.8, 1H), 4.77 (d, J = 8.1, 1H), 4.37 (td, J = 9.6, 4.0, 1H), 
3.82 – 3.65 (m, 3H), 3.63 – 3.47 (m, 2H), 3.33 – 3.22 (m, 4H), 1.42 (s, 3H), 1.35 (s, 3H).  13C 
NMR (101 MHz, CDCl3) δ 170.7, 134.0, 133.7, 130.9, 130.2, 128.4, 127.4, 126.6, 125.5, 125.4, 
124.8, 100.0, 99.1, 74.9, 71.0, 63.6, 62.4, 55.4, 54.7, 29.2, 19.2. 
 
              Compound 21 (92 mg, 85%); white solid; mp 86.0-88.0 °C. 
1
H NMR (400 MHz, 
CDCl3) δ 5.81 (t, J = 20.7, 1H), 4.66 (d, J = 3.8, 1H), 4.17 (td, J = 9.3, 3.8, 1H), 3.89 – 3.68 (m, 
3H), 3.65– 3.56(m, 2H), 3.37 (s, 3H), 3.08 (d, J = 3.1, 1H), 2.24 (t, J=7.6, 2H), 1.53 (s, 3H), 1.44 
(s, 3H), 1.37–1.19 (m, 9H), 0.87 (t, J = 6.7, 3H ). 13C NMR (101 MHz, CDCl3): δ 174.8, 99.8, 
98.8, 74.7, 71.4, 63.2, 62.2, 55.1, 54.1, 36.7, 31.6, 29.1, 29.0, 25.6, 22.6, 19.1, 14.0. 
 
             For compound 22: docosanoic acid (140 mg, 0.4 mmol) was mixed with 2 mL DCM and 
cooled in ice bath. 0.1 mL oxalyl chloride (0.04 mL, 0.5 mmol) was added to mixture slowly and 
followed by 1 drop anhydrous DMF. The mixture was stirred at room temperature for 2 hours at 
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which time the reaction was complete. The solvent was removed under nitrogen and product was 
used immediately following the general procedure of amide synthesis.  
 
              Compound 22 (99 mg, 83%); white solid; mp 53.0-54.0 °C. 
1
H NMR (400 MHz, 
CDCl3) δ 5.83 (t, J = 19.0, 1H), 4.66 (d, J = 3.9, 1H), 4.19 – 4.12 (m, 1H), 3.88–3.68 (m, 3H), 
3.64–3.57 (m, 2H), 3.36 (s, 3H), 2.3 –2.12 (m, 4H), 1.95–1.91 (m, 1H), 1.84–1.76 (m, 1H), 1.68–
1.57(m, 2H), 1.52 (s, 3H), 1.43(s, 3H), 1.41–1.21 (m, 9H). 13C NMR (101 MHz, CDCl3): δ 
174.7, 99.8, 98.8, 74.7, 71.3, 68.1, 63.2, 62.2, 55.1, 54.0, 36.6, 29.1, 29.1, 29.0, 28.9, 28.6, 28.4, 
25.5, 19.0, 18.3. 
 
General procedure for the synthesis of ureas. 
       4,6-O-Isopropylidene-Methyl-α-D-Glucosamine (50 mg, 0.214 mmol) was dissolved in 
anhydrous THF. The corresponding isocyanate (0.214 mmol) was added to the solution, which 
was then stirred at room temperature for 6 hours. The solvent was removed under N2. The crude 
product can be purified by flash chromatography on silica gel using the solvent system 2% 
methanol in DCM. 
 
            Compound 23 (140 mg, 92%); white solid; mp 105.0-107.0 °C. 
1
H NMR (400 MHz, 
CDCl3) δ  7.52 (s, 1H), 7.29 – 7.17 (m, 3H), 6.98 (m, 1H), 5.58 (t, J = 19.0, 1H), 4.72 (d, J = 3.8, 
1H), 4.04– 3.95 (m, 1H) 3.88– 3.73 (m, 3H), 3.67 – 3.58 (m, 2H), 3.34 (s, 3H), 1.50 (s, 3H), 1.41 
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(s, 3H). 
13
C NMR (101 MHz, CDCl3): δ 156.6, 138.6, 129.0, 123.2, 120.1, 99.9, 99.4, 74.6, 71.1, 
63.3, 62.3, 55.2, 55.1, 19.1. 
 
             Compound 24 (71 mg, 92%); white solid; mp 110.0-111.0 ºC. 
1
H NMR (400 MHz, 
CDCl3) δ 5.08 (dd, J = 18.8, 8.1, 2H), 4.67 (d, J = 3.8, 1H), 4.03 (s, 1H), 3.96 – 3.43 (m, 5H), 
3.36 (s, 3H), 2.16 (s, 1H), 1.90 (d, J = 10.8, 2H), 1.67 (dd, J = 9.4, 3.9, 2H), 1.52 (s, 3H), 1.42 (s, 
3H), 1.37-1.25 (m, 3H),  1.18–1.05(m, 3H). 13C NMR (101 MHz, CDCl3): δ 158.4, 99.8, 99.4 , 
74.7, 71.7, 63.2, 62.3, 55.3, 55.1, 49.2, 33.7, 33.5, 29.0, 25.5, 24.8, 19.1. 
 
            Compound 25 (74 mg, 85%); white solid; mp 132.0-133.0 ºC. 
1
H NMR (CDCl3, 400 
MHz) δ 8.30 – 7.95 (m, 1H), 7.95 – 7.78 (m, 1H), 7.70 (d, J = 8.2, 1H), 7.60 (d, J = 7.3, 1H), 
7.57 – 7.39 (m, 3H), 5.37 (d, J = 8.7, 1H), 4.62 (d, J = 3.8, 1H), 4.17 – 3.94 (m, 1H), 3.83 – 3.48 
(m, 6H), 3.15 (s, 3H), 1.49 (s, 3H), 1.39 (s, 3H). 
13
C NMR (101 MHz, CDCl3): δ 157.7, 134.4, 
133.0, 128.5, 126.5, 126.3, 126.3, 125.8, 122.3, 121.9, 99.8, 99.2, 74.6, 71.5, 63.2, 62.2, 55.3, 
55.1, 29.0, 19.0. 
 
          Compound 26 ( 73 mg, 91%); white solid; mp 53.0-54.0 °C. 
1
H NMR (400 MHz, CDCl3): 
δ 5.25 – 5.15 (m, 2H), 4.66 (d, J = 3.8, 1H), 3.89 – 3.68 (m, 4H), 3.63 – 3.56 (m, 2H), 3.35 (s, 
3H), 3.20 – 3.02 (m, 2H), 1.52 (s, 3H), 1.50 – 1.43 (m, 2H), 1.42 (s, 3H), 1.36 – 1.17 (m, 8H), 
0.86 (t, J = 6.8, 3H). 
13
C NMR (101 MHz, CDCl3): δ 159.2, 99.8, 99.4, 74.7, 71.5, 63.2, 62.3, 
55.2, 55.1, 40.6, 31.7, 29.0, 29.0, 26.9, 22.5, 19.1, 14.0. 
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            For compound 27: 10-undecynoic acid (39 mg, 0.2 mmol) was mixed with triethylamine 
(0.06 mL, 0.4 mmol) and diphenylphosphoryl azide (0.046 mL, 0.4 mmol) in 2 mL anhydrous 
THF. The mixture was heated at 60 °C for 2 hours and the reaction was complete. The product 
was used directly following the general procedure of urea synthesis. 
 
           Compound 27 (55 mg, 62%); white solid; mp 41.0-42.0 ºC. 
1
H NMR (400 MHz, CDCl3) δ 
5.00 – 4.78 (m, 2H), 4.65 (dd, J = 13.3, 9.6, 1H), 3.89–3.57 (m, 6H), 3.36 (s, 3H), 3.13 (d, J = 
6.5, 2H), 2.29 – 2.13 (m, 2H), 1.93 (t, J = 2.6, 1H), 1.81 (s, 1H), 1.53 (s, 3H), 1.51-1.45 (m, 3H), 
1.43 (s, 3H), 1.34-1.29 (m, 8H). 
13
C NMR (101 MHz, CDCl3): δ 159.0, 99.8, 99.3, 74.7, 71.9, 
68.1, 63.1, 62.3, 55.3, 55.1, 40.7, 30.0, 29.1, 29.1, 29.0, 28.6, 28.4, 26.8, 19.1, 18.3. 
 
            For compound 28: docosanoic acid (146 mg, 0.4 mmol) was mixed with triethylamine 
(0.12 mL, 0.8 mmol) and diphenylphosphoryl azide (0.18 mL, 0.8 mmol) in 2 mL anhydrous 
THF. The mixture was heated at 60 °C for 2 hours and the reaction was complete. The product 
was used directly following the general procedure of urea synthesis. 
 
           Compound 28 (108 mg, 65%); white solid; mp 92.0°C-94.0 °C. 
1
H NMR (400 MHz, 
CDCl3) δ 5.07 – 4.91 (m, 2H), 4.66 (t, J = 6.8, 1H), 3.91 – 3.68 (m, 4H), 3.65 – 3.56 (m, 2H), 
3.36 (s, 3H), 3.21– 3.06 (m, 2H), 1.53 (s, 3H), 1.50-1.44 (m, 1H), 1.43 (s, 3H), 1.37 – 1.16 (m, 
37H), 0.87 (t, J = 6.8, 3H). 
13
C NMR (101 MHz, CDCl3) δ 159.0, 99.8, 99.3, 74.7, 71.8, 63.2, 
62.3, 55.3, 55.1, 40.7, 31.9, 30.1, 29.7, 29.6, 29.6, 29.6, 29.3, 29.3, 29.1, 26.9, 22.7, 19.1, 14.1. 
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General procedure for deprotected ureas and amides. 
             Typically, the urea or amide product (50mg) from the previous step was mixed with 2ml 
85% acetic acid and stirred at room temperature for 6 hours. The reaction mixture was put under 
nitrogen and then under vacuum. The leftover solid was pure and no further purification was 
needed.  
 
             Compound 29 ( 42 mg, 96%); white solid; mp 157.0-158.0 °C. 
1
H NMR (400 MHz, 
DMSO) δ 7.60 (d, J = 8.0, 1H), 4.94 (d, J = 5.4, 1H), 4.64 (d, J = 5.5, 1H), 4.49 (dd, J = 12.2, 
4.8, 1H), 3.73 – 3.55 (m, 2H), 3.51 – 3.35 (m, 2H), 3.21 (s, 3H), 3.17 – 3.02 (m, 2H), 2.15 – 1.99 
(m, 2H), 1.54 – 1.37 (m, 2H), 1.33 – 1.11 (m, 3H), 0.83 (t, J = 6.9, 4H).13C NMR (101 MHz, 
DMSO): δ 172.5, 97.9, 72.7, 70.9, 70.7, 60.8, 54.3, 53.7, 35.1, 30.8, 25.0, 21.9, 13.9. HRMS 
Calcd for C13H26NO6 [M + 1]
+
, 298.1760; found, 298.1756.  
 
            Compound 30 (42 mg, 96%); white solid; mp 155.0-156.0 °C. 
1
H NMR (400 MHz, 
DMSO) δ 7.69 (d, J = 8.1, 1H), 4.51 (d, J = 3.5, 1H), 3.72 – 3.54 (m, 2H), 3.50 – 3.36 (m, 2H), 
3.22 (s, 3H), 3.08 (dd, J = 21.4, 12.3, 2H), 2.75 (t, J = 2.6, 1H), 2.26 – 2.05 (m, 4H), 1.64 (p, J = 
7.3, 2H). 
13
C NMR (101 MHz, DMSO): δ 171.8, 97.9, 84.3, 72.7, 71.4, 70.8, 70.7, 60.8, 54.3, 
53.7, 34.1, 24.4, 17.4. HRMS Calcd for C13H21NO6Na
+
 [M + Na]
+
, 310.1267; found, 310.1265. 
 
           Compound 31 ( 42 mg, 90%) white solid; mp 149-151°C. NMR spectrum only showed 
the peaks between 1ppm and 2 ppm. HRMS calculated for C29H58NO6 [M+H], 516.4264; found, 
516.4272.  
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            Compound 32 (43 mg, 97%); white solid; mp 220.0-221.0°C.
 1
H NMR (400 MHz, 
DMSO) δ 8.12 (d, J = 7.7, 1H), 7.88 (d, J = 7.6, 2H), 7.51 (t, J = 7.2, 1H), 7.44 (t, J = 7.5, 2H), 
4.68 (d, J = 3.4, 1H), 3.92 – 3.80 (m, 1H), 3.68 (dd, J = 17.6, 7.6, 2H), 3.49 (d, J = 11.0, 1H), 
3.23 (s, 3H), 3.18 (t, J = 9.2, 2H). 
13
C NMR (101 MHz, DMSO): δ 166.5, 134.3, 131.2, 128.1, 
127.5, 97.8, 72.8, 70.8, 70.3, 60.9, 54.8, 54.4. HRMS Calcd for C14H20NO6 [M + 1]
+
, 298.1291; 
found, 298.1287. 
 
            Compound 33 (43 mg, 95%) Compound decomposed upon heating, so no melting point 
could be obtained.  
1
H NMR (400 MHz, CD3OD) δ 8.28 – 8.22 (m, 1H), 7.96 (d, J = 8.3, 1H), 
7.93 – 7.88 (m, 1H), 7.65 (dd, J = 7.0, 1.1, 1H), 7.57 – 7.48 (m, 3H), 4.95 (d, J = 3.6, 1H), 4.22 
(dd, J = 10.7, 3.6, 1H), 3.87 (dd, J = 11.8, 2.3, 1H), 3.81 – 3.70 (m, 2H), 3.60 (ddd, J = 9.7, 5.6, 
2.3, 1H), 3.49 – 3.40 (m, 5H), 3.34 (s, 1H).  13C NMR (101 MHz, CD3OD) δ 172.8, 135.7, 135.1, 
131.4, 129.3, 127.9, 127.4, 126.5, 126.4, 125.9, 99.9, 73.8, 72.7, 72.5, 62.8, 56.1, 55.7.  HRMS 
Calcd  for C18H21NO6Na
+
 [M+Na], 370.1267; found, 370.1269. 
 
           Compound 34 (42 mg, 95%); white solid; mp 156.5-157.5 °C. 
1
H NMR (400 MHz, 
CDCl3) δ 4.61 (d, J = 3.6, 1H), 3.87 (dt, J = 25.5, 12.8, 1H), 3.77 – 3.68 (m, 2H), 3.61 – 3.37 (m, 
4H), 3.29 (s, 3H), 2.20 – 2.13 (m, 1H), 1.66 – 1.45 (m, 3H), 1.22 (dd, J = 7.6, 4.3, 10H), 0.81 (t, 
J = 6.8, 1H). 
13
C NMR (101 MHz, CDCl3): δ 175.1, 115.3, 98.3, 72.3, 71.5, 70.7, 61.5, 55.0, 
53.4, 36.3, 31.5, 29.0, 28.8, 25.5, 22.4, 13.8. 
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              Compound 35 (43 mg, 95%); white solid; mp 122.0-124.0°C. 
1
H NMR (400 MHz, 
CDCl3) δ 4.64 (d, J = 3.6, 1H), 3.94 (dd, J = 10.3, 3.6, 1H), 3.78 (d, J = 3.1, 2H), 3.65 – 3.41 (m, 
4H), 3.33 (s, 3H), 2.28 – 2.07 (m, 5H), 1.91 (t, J = 2.6, 1H), 1.52 (ddd, J = 22.0, 14.4, 7.0, 5H), 
1.40 – 1.13 (m, 6H).13C NMR (101 MHz, CDCl3): δ 175.0, 98.4, 85.9, 72.7, 71.4, 70.9, 68.0, 
61.7, 55.0, 53.4, 36.4, 29.1, 29.0, 28.8, 28.5, 28.3, 25.5, 18.2. HRMS Calcd for C18H31NO6 [M + 
1]
+
, 358.2234; found, 358.2230.  
 
            Compound 36 (43 mg, 96%), white solid; mp 196.0-198.0 °C. 
1
H NMR (400 MHz, 
DMSO) δ 8.56 (d, J = 13.2, 1H), 7.34 (d, J = 8.2, 2H), 7.19 (t, J = 7.8, 2H), 6.86 (t, J = 7.3, 1H), 
5.99 (d, J = 8.5, 1H), 4.58 (d, J = 3.4, 1H), 3.69 – 3.51 (m, 4H), 3.26 (s, 3H), 3.20 – 3.08 (m, 
2H). 
13
C NMR (101 MHz, DMSO): δ 155.1, 140.5, 128.8, 121.1, 117.5, 98.6, 72.9, 71.8, 70.8, 
60.9, 54.4, 53.9. HRMS Calcd for C14H21N2O6 [M + 1]
+
, 313.1400; found, 313.1403. 
 Compound 37 (43 mg, 96% ); white solid; mp 230.0-232.0 ºC.
 1
H NMR (400 MHz, DMSO) δ 
5.97 (d, J = 7.8, 1H), 5.57 (d, J = 8.1, 1H), 4.93 (s, 1H), 4.78 (s, 1H), 4.49 (dd, J = 15.7, 9.3, 1H), 
3.72 – 3.54 (m, 2H), 3.50 –3.30 (m, 2H), 3.23 (s, 3H), 3.15 – 2.97 (m, 1H), 1.79 – 1.55 (m, 4H), 
1.49 (m, 2H), 1.31 – 0.95 (m, 5H).13C NMR (101 MHz, DMSO): δ 157.5, 98.7, 72.8, 72.0, 71.0, 
61.0, 54.3, 54.1, 47.7, 33.4, 33.3, 25.3, 24.4. HRMS Calcd for C14H27N2O6 [M + 1]
+
, 319.1869; 
found, 319.1866. 
 
             Compound 38 (43 mg, 95%); white solid; mp 223.0-224.0 ºC.
 1
H NMR (400 MHz, 
DMSO) δ 8.64 (d, J = 16.6, 1H), 8.12 (d, J = 8.2, 1H), 8.06 (d, J = 7.6, 1H), 7.87 (d, J = 8.1, 
1H), 7.56 – 7.46 (m, 3H), 7.39 (t, J = 7.9, 1H), 6.65 (d, J = 8.4, 1H), 5.02 (d, J = 5.3, 1H), 4.95 
(d, J = 5.5, 1H), 4.65 (d, J = 3.4, 1H), 4.55 (t, J = 5.8, 1H), 3.67 (dd, J = 14.3, 3.9, 3H), 3.54 – 
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3.44 (m, 4H), 3.26 – 3.11 (m, 2H).  13C NMR (101 MHz, DMSO): δ 155.5, 135.2, 133.8, 128.4, 
126.0, 125.8, 125.4, 125.1, 121.8, 121.3, 115.7, 98.6, 72.9, 71.9, 70.9, 60.9, 55.3, 54.4, 54.2. 
HRMS Calcd for C18H23N2O6 [M + 1]
+
, 363.1556; found, 363.1554. 
 
             Compound 39 (42 mg, 94%); white solid; mp 185.0-186.0 °C.
 1
H NMR (400 MHz, 
DMSO) δ 5.61 (d, J = 8.3, 1H), 4.93 (d, J = 5.5, 1H), 4.77 (d, J = 5.6, 1H), 4.56 – 4.45 (m, 1H), 
3.67 – 3.57 (m, 1H), 3.54– 3.26 (m,3H ), 3.23 (s, 3H), 3.14 – 3.03 (m, 1H), 2.94 (dd, J = 12.8, 
6.4, 2H), 1.42 – 1.13 (m, 10H), 0.84 (t, J = 6.8, 3H). 13C NMR (101 MHz, DMSO): δ 158.1, 
98.7, 72.8, 72.0, 70.9, 60.9, 54.3, 54.2, 39.2, 31.3, 30.0, 28.5, 26.4, 22.1, 14.0. HRMS Calcd for 
C15H31N2O6 [M + 1]
+
, 335.2182; found, 335.2182. 
 
            Compound 40 (43 mg, 95%); white solid; mp 131.0-132 °C.
 1
H NMR (400 MHz, DMSO) 
δ 5.60 (d, J = 8.3, 1H), 4.92 (d, J = 5.6, 1H), 4.76 (d, J = 5.6, 1H), 4.52 – 4.47 (m, 1H), 3.67– 
3.55 (m, 1H), 3.51– 3.24 (m, 2H), 3.22 (s, 3H), 3.13-3.04 (m, 1H), 2.99 – 2.88 (m, 2H), 2.73– 
2.67 (m, 2H), 2.17– 2.05 (m, 2H), 1.47 – 1.12 (m, 11H). 13C NMR (101 MHz, DMSO): δ 158.1, 
98.8, 84.6, 72.8, 72.0, 71.1, 70.9, 60.9, 54.3, 54.2, 39.2, 30.0, 28.7, 28.5, 28.1, 28.0, 26.4, 17.7. 
HRMS Calcd for C18H33N2O6 [M + 1]
+
, 373.2339; found, 373.2344. 
 
            Compound 41 (44 mg, 95%); white solid; mp 145.0°C-147.0 °C. NMR spectrum only 
showed the peaks between 1ppm and 2 ppm. HRMS calcd C29H59N2O6 [M + 1]
+
, 531.4373; 
found, 531.4374 
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                                                            Chapter IV 
 
Diacetylene Containing Carbohydrate Based Low Molecular Weight Gelators and the 
Effect of Aromatic Protecting Group at 4, 6-Position of α-D-Glucose. 
 
Abstract: The promising results obtained from glucosamine based LMWGs encouraged us to 
synthesize diacetylene containing organogelators. We linked α-D-glucosamine with diacetylene 
group and studied gelation properties of synthesized compounds. We have synthesized various 
diacetylene derivatives using diacetylene containing fatty acids, these include 5, 7-hexadeca 
diynoic acid, 10, 12-octadecadiynoic acid, 10, 12-tricosadiynoic acid, 10, 12-docosadiyndioic 
acid, and 10, 12-decosadiyndioic acid. These compounds not only have the long carbon alkyl 
group, but also show polymerization under UV or heat.  
         
             In this chapter, besides the preparation of diacetylene containing glucosamine 
derivatives, various headgroups were also preliminarily studied in order to improve gelation 
efficacy. The benzyl group is usually used as protecting group at 4, 6 position of sugar head 
group. In most cases, it provides π-π stacking among molecules. Two additional methoxyl 
substituents were introduced to the phenyl ring in order to understand the influence of structure 
towards gelation.  
            
Keywords: diacetylene, glucosamine, protecting group of glucose. 
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                                                                Introduction 
             Polydiacetylenes (PDAs) has been studied for more than 2 decades.
1-5
 It has found 
applications in different areas like polymer crystals, Langmiur-Blodgett films, biosensors, optical 
electronic devices.
6-17 
Our group has been studying diacetylene functional group since 2005.
18, 19
 
Diacetylene compounds can be polymerized under UV, heat, pH change as shown in Figure 
4.1.
20, 21
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                                        Figure 4.1  Polymerization of diacetylene 
             The polydiacetylenes usually show blue color. Continuous heat will turn the blue 
polymer into red.  It is believed that this change is due to distortion of side chain (R and R’). 
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                           Figure 4.2 The distortion of R, R’ group lead to color change 
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        Previously, we studied the 4, 6-O-benzelydene-methyl-α-D-glucopyranoside along with 
the following diacetylene compounds. 
18, 19 
       
9-Phenylnonan-4,6-diynoic acid
O
HO
7-Phenylheptan-4,6-diynoic acid O
HO
Decan-4,6-diynoic acid
O
HO
Heptan-4,6-diynoic Acid
O
HO
10,12-Tricosadiynoic Acid O
OH
8,10-Heneicosadiynoic Acid
O
OH
5, 7-Hexadecadiynoic Chloride
O
OH
Heptan-4,6-diynoic Acid
O
OH
1
2
3
4
5
6
7
8                  
   Figure 4.3 The fatty acids that have been used in the synthesis of gelators by our group 
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           The hydroxyl groups at 2- and3-positions were esterified using the above diacetylene 
groups. The reaction usually yields three products like the esterification in chapter 1.  The gel 
tests results of the esters with 10,12-tricosadiynoic, 8,10-heneicosadiynoic group,  5, 7-
hexadecadiynoic  group behaved well in hexane, ethanol, ethanol/water (1:1). However the 
minimum gelation concentrations are generally about 2 mg/mL in water. To further explore 
better gelator, we studied 4, 6-O-benzelidene-deoxy-α-D-glcucopyranoside which can be found 
in second chapter. Only 10, 12-tricosadiynoyl group, 8, 10-heneicosadiynoylgroup  were studied, 
because these two diacetylenes were the ones that performed the best in the methoxy series. The 
gelation results showed that two dimers (structure 9, 10) are good gelators in EtOH: water (1:2). 
The monomers did not gel in the five testing solvents.  
                         
O
O
O
O
O
Ph
O
O
O
O
O
O
O
Ph
O
O
9
10
                             
                                               Figure 4.4 The structure of dimers  
            The study of α-D-glucosamine (Chapter 3) provided us with some very good gelators 
especially the 21 carbon straight chain alkyl amide and urea. Considering some of diacetylenes 
are very similar to the long chain alkyl group, in order to obtain diacetylene containing gelators, 
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we synthesized amides and ureas using α-D-glucosamine and long chain diacetylenes. The 
synthesis was similar to the synthesis of amides and ureas in Chapter 3. Besides the mono 
amides and ureas, we also studied diacetylene diacid reacting with α-D-glucosamine which 
yielded bis amides or bis-ureas. The gelation property was then tested. 
 
        Our group not only synthesizes different gelators but also explores the application of 
LMWGs. We want to study the acid stability of gels and acid trigger release system.  To do this, 
we synthesized the following head group (11, 12). We have found out that the protecting group 
at 4, 6 position of head group (11, 12) is liable to acid condition, so the gel formed by gelators of 
11, 12 will be subject to acid change. The synthesis is very much the same as 4, 6-O-
benzyledene-methyl-α-D-glucosamine and 4, 6-O-benzylene-methyl-α-D-glucopyranoside.  
 
             
O
O
HO
OH
O
OCH3
MeO
OMe
O
O
HO
NH2
O
OCH3
MeO
OMe
11 12  
                                      Figure 4.5 The structures of sugar head groups 
           Different esters and amides were synthesized and tested. The amides behaved very well, 
but esters did not form gel in five test solvents.  
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                                                        Results and Discussion 
       The synthesis started from 4, 6-O-isopropyledene-methyl-α-D-glucosamine reacting with 
acyl chloride or isocyanate to form amides and ureas. Because diacetylene isocyanate and acyl 
chloride were not commercially available, they were all synthesized in situ. Acyl chlorides of 
14A, 15A, 16A, 17 were synthesized by reacting the corresponding acid with oxalyl chloride. 
Isocyanates of 14B, 15B, 16B were synthesized by curtius rearrangement. Because diacetylenes 
are light sensitive, all reactions were carried out in foil wrapped containers. 
                        
O
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HO
NH2
O
OCH3
O
O
HO
NH
O
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H
N
O
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                           Scheme 4.1 The synthesis scheme of diacetylene amides and ureas 
122 
 
           The products yields are shown in Table 4.1 The gel tests results are shown in Table 4.2. 
                                  Table 4.1 Yields of amides and ureas of Compound 13 
Compound 14A 14B 15A 15B 16A 16B 17 
Yield 82 % 71 % 79 % 65 % 78 % 65 % 76 % 
 
                 Table 4.2 Library of amide and urea derivatives and their gel tests results.                    
Compound H
2
O  Hexane  Ethanol  DMSO:H
2
O 
(1:2)  
EtOH: 
H
2
O(1:2)  
EtOH:H2O 
(1:1) 
Toluene THF 
       14A P  I  S  P  P  I S S 
       14B I I S P I P S S 
       15A P  I  S  I  P  P S S 
       15B I I S P P P S S 
       16A I  I  S  I  I  I S S 
       16B P I S I P P S S 
       17A I  I  S  P  I  P S S 
 
All concentrations are in mg/mL; G, gel at room temperature; the numbers after G are minimum 
gelation concentrations; P, precipitation; S, soluble at~20 mg/mL; the ratio of solvents in 
parenthesis. 
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             The above compounds were not tested in the usually five solvents, because we learned 
from Chapter 3 that protected compounds were not gelators in those five solvents. Three new 
solvents were tested. They are EtOH/H2O= 1: 1, THF, toluene. All the compounds are soluble in 
THF and toluene. In EtOH/H2O= 1: 1, five compounds precipitate out and two compounds are 
insoluble.       
             Five compounds were selected for deprotection. The deprotection was carried out in 
trifluoroacetic acid. No workup was needed. Trifluoroacetic acid, solvent and byproduct acetone 
were blown away under nitrogen. 
                              
                      Figure 4.6 The synthesis of deprotected amides and ureas 
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               The gelation property was tested in five solvents. The results are shown in Table 4.3. 
                                     Table 4.3 The yields of deprotected amides and ureas 
Compound 18 19 20 21 22 
Yield 96 % 95 % 95 % 95 % 95 % 
 
      Table 4.4 Library of deprotected amide and urea derivatives and their gel tests results.                    
Compound Hexane H2O EtOH EtOH:H2O
(1:2) 
DMSO:H2O 
(1:2) 
Isopropanol  Toluene 
18 I P S P P S S 
19 I I S P I S S 
       20 I P S I I S S 
       21 I I S P P S S 
       22 I I S P P S S 
 
All concentrations are in mg/mL; G, gel at room temperature; the numbers after G are minimum 
gelation concentrations; P, precipitation; S, soluble at~20 mg/mL; the ratio of solvents in 
parenthesis. 
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            The gel test results showed that none of compounds formed gel in the five testing 
solvents. The solubility of the synthesized compounds was very different from that of amides 
and ureas from Chapter 3. The compounds from chapter 3 are insoluble in chloroform and NMR 
had to be taken in d-DMSO. They are good gelators in water, DMSO/water (1: 2), Ethanol/water 
(1: 2). However the diacetylene compounds after deprotection showed very good solubility in 
chloroform. Most NMRs were taken in CDCl3 with only a tiny drop of d-methanol. From this we 
can tell that diacetylene group changed polarity significantly.  
            The new protecting group for 4, 6 position was synthesized by reacting 3, 4-
dimethoxybenzaldehyde with trimethyl orthoformate. The product was reacted directly with N-
acetyl-methyl-α-D-glucosamine.  
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                                  Scheme 4.2 The synthesis of compound 11, 12 
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             After obtaining the headgroups (11, 12), different amides and esters were synthesized. 
The selection of functional groups was based on previous researches.  
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                              Scheme 4.3 The synthesis of esters from compound 12 
 
           
O
O
HO
NH2
O
OCH3
MeO
OMe
O
O
HO
NH
O
OCH3
MeO
OMe O
R
R= 31 32 33
Acyl chloride
11
 
                         Scheme 4.4 The synthesis of amide derivatives of compound 11 
               The synthesis of different esters followed the same method. The diesters and 2-
monoesters are the main products. The amide formation was straightforward. The acyl chloride 
of compound 28 was synthesized in situ. The yields are shown below. The products were tested 
in five solvents. The results are shown in table 4.6.  
 
127 
 
 
                                               Table 4.5 Yields of esters (A,B) 
 
  Compound 
 
Total Yields 
O
O
O
O
O
OCH3
MeO
OMe
O
R
O
R
A  
O
O
HO
O
O
OCH3
MeO
OMe O
RB  
26 90 % 7 % 83 % 
27 91 % 25 % 66 % 
28 90 % 15 % 75 % 
29 92 % 23 % 59 % 
30 90 % 15 % 75 % 
 
 
                                                    Table 4.6 Yields of Amides 
Compound 31 32 33 
Yield 78 % 72 % 83 % 
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                               Table 4.7 Gel tests results of ester and amide derivatives.  
Compound Hexane H2O EtOH EtOH:H2O(1:2) DMSO:H2O(1:2) 
26A         I         P         S             P              P 
26B I P P P P 
27A I P S P P 
27B I G 20 S P P 
28A I I S P P 
28B I P S P P 
29A I P S P P 
29B I P S P P 
30A I P S P P 
30B I P S P P 
31 I I G 10 G 5 G 5 
32 I I G 20 G 20 G 20 
33 I I G 20 G 5 G 3 
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All concentrations are in mg/mL; G, gel at room temperature; the numbers after G are minimum 
gelation concentrations; P, precipitation; S, soluble at~20 mg/mL; the ratio of solvents in 
parenthesis. 
 
            Some of images from optical microscope are shown below. The gel of compound 31 
consisted of long and thin tubes. This showed clearly in 500x optical micrographs. This tube is 
different from the one formed by compound 32. In Figure 4.9, we can see that tubes are thicker 
than those in Figure 4.7. Much shorter tubes were seen in Figure 4.11, this results was consistent 
with what we saw in Figure 3.6. It seemed that when the gel was at very low concentration, tubes 
or fibers were shorter and smaller. 
 
  Figure 4.7 200x Optical micrographs of gel formed by Compound 31 at 5 mg/mL in DMSO: 
H2O (1: 2).  
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 Figure 4.8 500x Optical micrographs of gel formed by compound 31 at 5 mg/mL in DMSO:H2O 
(1: 2).  
 
 
 Figure 4.9 200x Optical micrographs of gel formed by compound 32 at 20 mg/mL in DMSO: 
H2O (1: 2).  
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 Figure 4.10 500x Optical micrographs of gel formed by compound 32 at 20 mg/mL in DMSO: 
H2O (1: 2).  
 
                     
  Figure 4.11 500x Optical micrographs of gel formed by compound 33 at 3 mg/mL in DMSO: 
H2O (1: 2).  
 
            When we compare the gel tests results of esters (26-30) with those of 4, 6-O-
benzyledene-methyl-α-D-glucopyranoside esters, we didn’t see much improvement. Only one 
compound formed gel in water at 20 mg/mL. Precipitation can be seen in most test solvents. It 
can be due to the tight pack of molecules. 
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            On the other hand, the amides behaved much better. All of them gelled ethanol, DMSO: 
water (1: 2), EtOH: water (1: 2). The best one formed gel at 3 mg/mL in DMSO: water (1: 2). 
This minimum gelation concentration was not as good as amides of 4, 6-O-benzylidene-methyl-
α-D-glucosamine.22 It can be due to some distortion of π-π stacking. However none of those 
amides of 4, 6-O-benzylidene-methyl-α-D-glucosamine gel in ethanol,22 but the dimethoxyl 
benzylidene acetal derivatives formed efficient gels in ethanol. The two methoxy groups on the 
phenyl ring could act as hydrogen bond acceptors which interact with hydroxyl group at 3 
position and solvent ethanol. It can also interact with NH- from the amide group. However, it 
will be more conclusive if an X-ray crystal structure could be obtained.   
 
           When we look into the gelation details of compound 31, 32, 33, we can tell that amides 
worked much better. Each of amides formed gel in three different solvent: EtOH, EtOH:H2O 
(1:2), DMSO:H2O (1:2). The hydrogen bonding from amide was the main contributor of 
gelation.  
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                                                              Conclusion 
           The introduction of diacetylene into α-D-glucosamine significantly changed polarity of 
molecules. Even though none of the synthesized compound formed gel in testing solvents, it 
gave us an idea how diacetylene would affect polarity and gel formation and what modification 
may lead to effective gelatiors. 
 
           3, 4-Dimethoxy benzyl group was used as protecting group at 4, 6-position in α-D-glucose 
and α-D-glucosamine. Only one synthesized ester formed gel at 20 mg/mL in water. This is 
comparable to the unsubstituted benzylidene acetal series, in which the same ester none of esters 
formed gel. In the case of amides, the gel tests results are much better. All 3 synthesized amides 
can form gel in ethanol, DMSO: water (1: 2), EtOH:water (1: 2). The minimum gelation 
concentration reached 3 mg/mL in DMSO: water (1: 2). The two additional methoxy group 
definitely helped, because same amides using benzylidene acetalas protecting group did not form 
gel in ethanol. The two methoxy groups on phenyl ring can act as hydrogen bond acceptor and 
interact with solvent ethanol. The headgroup 12 is worthy of further research to obtain effective 
organogelators.  
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                                                        Experimental section 
General procedure for the synthesis of amide 
            4, 6-O-Isopropylidene-Methyl-α-D-Glucosamine (50 mg, 0.214 mmol) was dissolved in 
anhydrous THF with pyridine (1.07 mmol). The corresponding acyl chloride (0.214 mmol) was 
added to the solution, which was then stirred at room temperature for 8 hours. The reaction 
mixture was worked up by DCM extraction. The crude product can be purified by flash 
chromatography on silica gel using the solvent system hexane and ethyl acetate. 
 
General procedure for the synthesis of ureas 
       4, 6-O-Isopropylidene-Methyl-α-D-Glucosamine (50 mg, 0.214 mmol) was dissolved in 
anhydrous THF. The corresponding isocyanate (0.214 mmol) was added to the solution, which 
was then stirred at room temperature for 6 hours. The solvent was removed under N2. The crude 
product can be purified by flash chromatography on silica gel using the solvent system 2% 
methanol in DCM.  
 
            For compound 14A: 5,7-hexadecadiynoic acid (102 mg, 0.4 mmol) was mixed with 2 mL 
DCM and cooled in ice bath. 0.1 mL oxalyl chloride (0.04 mL, 0.5 mmol) was added to mixture 
slowly and followed by 1 drop anhydrous DMF. The mixture was stirred at room temperature for 
2 hours at which time the reaction was complete. The solvent was removed under nitrogen and 
product was used immediately following the general procedure of amide synthesis.  
 
135 
 
 
             Compound 14A (131 mg, 82%); colorless liquid.
 1
H NMR (400 MHz, CDCl3) δ 5.92 (d, 
J = 8.7, 1H), 4.67 (d, J = 3.8, 1H), 4.18 (td, J = 9.4, 3.8, 1H), 3.90 – 3.83 (m, 1H), 3.82 – 3.68 
(m, 2H), 3.66 – 3.56 (m, 2H), 3.38 (s, 3H), 2.49 (t, J = 7.4, 2H), 2.44– 2.20 (m,5H),  1.93 – 1.79 
(m, 3H), 1.53 (s, 3H), 1.44 (s, 3H), 1.43– 1.20 (m, 9H), 0.88 (t, J = 6.7, 4H). 13C NMR (101 
MHz, CDCl3) δ 173.6, 99.9, 98.8, 78.1, 76.0, 74.7, 71.2, 66.4, 65.0, 63.2, 62.2, 55.2, 54.1, 35.0, 
31.8, 29.2, 29.1, 29.0, 28.8, 28.3, 23.8, 22.6, 19.2, 19.0, 18.4, 14.1. 
 
            For compound 14B: 5,7-hexadecadiynoic acid (119 mg, 0.5 mmol) was mixed with 
triethylamine (0.13 mL, 1 mmol) and diphenylphosphoryl azide (0.21 mL, 1 mmol) in 2 mL 
anhydrous THF. The mixture was heated at 60 °C for 2 hours and the reaction was complete. The 
product was used directly following the general procedure of urea synthesis. 
 
            Compound 14B (116 mg, 71%); colorless liquid.
 1
H NMR (400 MHz, CDCl3) δ 5.23 (t, J 
= 5.5, 1H), 5.12 (d, J = 8.6, 1H), 4.67 (d, J = 3.8, 1H), 3.89 – 3.69 (m, 2H), 3.64 – 3.55 (m, 1H), 
3.36 (s, 3H), 3.31 – 3.16 (m, 1H), 2.31 (t, J = 6.9, 2H), 2.23 (t, J = 7.1, 2H), 1.70 (p, J = 6.9, 2H), 
1.53 (s, 3H), 1.52 – 1.45 (m, 2H), 1.42 (s, 3H), 1.40 – 1.18 (m, 11H), 0.87 (t, J = 6.8, 4H). 13C 
NMR (101 MHz, CDCl3) δ 159.0, 99.8, 99.3, 78.1, 76.2, 74.7, 71.6, 66.0, 65.0, 63.2, 62.3, 55.3, 
55.2, 39.4, 31.8, 29.2, 29.1, 29.0, 28.8, 28.6, 28.3, 22.6, 19.2, 19.1, 16.7, 14.0. 
 
            For compound 15A: 10,12-octadecadiynoic acid (114 mg, 0.4 mmol) was mixed with 2 
mL DCM and cooled in ice bath. 0.1 mL oxalyl chloride (0.04 mL, 0.5 mmol) was added to 
mixture slowly and followed by 1 drop anhydrous DMF. The mixture was stirred at room 
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temperature for 2 hours at which time the reaction was complete. The solvent was removed 
under nitrogen and product was used immediately following the general procedure of amide 
synthesis.  
 
              Compound 15A (134 mg, 79%); colorless liquid.
 1
H NMR (400 MHz, CDCl3) δ 5.85 (d, 
J = 8.6, 1H), 4.66 (d, J = 3.9, 1H), 4.16 (td, J = 9.3, 3.9, 1H), 3.89 – 3.82 (m, 1H), 3.80 – 3.68 
(m, 2H), 3.65 – 3.53 (m, 2H), 3.36 (s, 3H), 2.23 (t, J = 7.3, 6H), 1.69 – 1.56 (m, 3H), 1.52 (s, 
3H), 1.50 – 1.45 (m, 2H), 1.43 (s, 3H), 1.41 – 1.18 (m, 11H), 0.88 (t, J = 7.0, 4H). 13C NMR (101 
MHz, CDCl3) δ 174.7, 99.8, 98.8, 77.6, 77.4, 74.7, 71.3, 65.3, 65.2, 63.2, 62.2, 55.1, 54.1, 36.6, 
31.0, 29.2, 29.1, 29.0, 28.9, 28.7, 28.2, 28.0, 25.5, 22.1, 19.1, 19.0, 13.9. 
 
             For compound 15B: 10,12-octadecadiynoic acid (114 mg, 0.4 mmol) was mixed with 
triethylamine (0.11 mL, 0.8 mmol) and diphenylphosphoryl azide (0.18 mL, 0.8 mmol) in 2 mL 
anhydrous THF. The mixture was heated at 60 °C for 2 hours and the reaction was complete. The 
product was used directly following the general procedure of urea synthesis. 
 
            Compound 15B (113 mg, 65%); colorless liquid. 
 1
H NMR (400 MHz, CDCl3) δ 4.95 (d, 
J = 8.5, 1H), 4.85 (d, J = 23.1, 1H), 4.67 (d, J = 3.8, 1H), 3.90 – 3.82 (m, 1H), 3.81 – 3.67 (m, 
2H), 3.63 – 3.53 (m, 1H), 3.36 (s, 3H), 3.22 – 3.05 (m, 1H), 2.23 (t, J = 6.9, 3H), 1.53 (s, 3H), 
1.52 – 1.42 (m, 5H) 1.43 (s, 3H), 1.40 – 1.20 (m, 15H), 0.88 (t, J = 7.0, 3H). 13C NMR (101 
MHz, CDCl3) δ 159.0, 99.8, 99.3, 77.6, 77.4, 74.7, 71.9, 65.3, 65.2, 63.1, 62.3, 55.3, 55.1, 40.6, 
31.0, 30.0, 29.1, 29.0, 28.9, 28.7, 28.2, 28.0, 26.8, 22.1, 19.1, 19.0, 13.9. 
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             For compound 16A: 10,12-tricosadiynoic acid (143 mg, 0.4 mmol) was mixed with 2 
mL DCM and cooled in ice bath. 0.1 mL oxalyl chloride (0.04 mL, 0.5 mmol) was added to 
mixture slowly and followed by 1 drop anhydrous DMF. The mixture was stirred at room 
temperature for 2 hours at which time the reaction was complete. The solvent was removed 
under nitrogen and product was used immediately following the general procedure of amide 
synthesis.  
 
            Compound 16A (151 mg, 78%); colorless liquid.
 1
H NMR (400 MHz, CDCl3) δ 5.84 (d, J 
= 8.6, 1H), 4.66 (d, J = 3.9, 1H), 4.16 (td, J = 9.3, 3.9, 1H), 3.86 (dd, J = 10.3, 4.3, 1H), 3.80 – 
3.68 (m, 2H), 3.64 – 3.53 (m, 3H), 3.36 (s, 4H), 2.23 (t, J = 6.8, 8H), 1.69 – 1.56 (m, 3H), 1.52 
(s, 5H), 1.51 – 1.45 (m, 5H), 1.43 (s, 4H), 1.40 – 1.16 (m, 33H), 0.87 (t, J = 6.8, 4H). 13C NMR 
(101 MHz, CDCl3) δ 174.7, 99.8, 98.8, 77.6, 77.4, 74.7, 71.4, 65.3, 65.2, 63.2, 62.2, 55.1, 54.1, 
36.6, 31.9, 29.5, 29.4, 29.3, 29.1, 29.0, 28.9, 28.8, 28.7, 28.3, 28.2, 25.5, 22.6, 19.2, 19.1, 19.0, 
14.1. 
 
 
           For compound 16B: 10,12-tricosadiynoic acid (143 mg, 0.4 mmol) was mixed with 
triethylamine (0.12 mL, 0.8 mmol) and diphenylphosphoryl azide (0.18 mL, 0.8 mmol) in 2 mL 
anhydrous THF. The mixture was heated at 60 °C for 2 hours and the reaction was complete. The 
product was used directly following the general procedure of urea synthesis. 
 
          Compound 16B (129 mg, 65%); colorless liquid. 
 1
H NMR (400 MHz, CDCl3) δ 4.83 (d, J 
= 8.5, 1H), 4.73 (s, 1H), 4.67 (d, J = 3.8, 1H), 3.93 – 3.82 (m, 1H), 3.80 – 3.66 (m, 1H), 3.65 – 
3.52 (m, 2H), 3.36 (s, 3H), 3.21 – 3.07 (m, 1H), 2.23 (t, J = 6.9, 4H), 1.53 (s, 3H), 1.52 – 1.43 
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(m, 4H), 1.44 (s, 3H), 1.41 – 1.16 (m, 26H), 0.87 (t, J = 6.7, 3H). 13C NMR (101 MHz, CDCl3) δ 
158.9, 99.8, 99.2, 77.6, 77.4, 74.7, 72.1, 65.3, 65.2, 63.1, 62.2, 55.7, 55.4, 55.1, 40.7, 31.9, 30.0, 
29.5, 29.4, 29.3, 29.1, 29.0, 28.9, 28.8, 28.7, 28.3, 28.2, 26.8, 22.7, 19.2, 19.1, 19.0, 14.1. 
 
            For compound 17: 10,12-docosadiyndioic acid (71 mg, 0.2 mmol) was mixed with 2 mL 
DCM and cooled in ice bath. 0.1 mL oxalyl chloride (0.04 mL, 0.4 mmol) was added to mixture 
slowly and followed by 1 drop anhydrous DMF. The mixture was stirred at room temperature for 
2 hours at which time the reaction was complete. The solvent was removed under nitrogen and 
product was used immediately following the general procedure of amide synthesis.  
 
            Compound 17  (118 mg, 76%) colorless liquid. 
 1
H NMR (400 MHz, CDCl3) δ 5.93 (d, J 
= 8.7, 2H), 4.66 (d, J = 3.8, 2H), 4.14 (td, J = 9.4, 3.8, 2H), 3.87 – 3.81 (m, 2H), 3.79 – 3.68 (m, 
4H), 3.64 – 3.52 (m, 4H), 3.35 (s, 6H), 2.22 (t, J = 7.2, 8H), 1.65 – 1.57 (m, 4H), 1.51 (s, 6H), 
1.49 – 1.44 (m, 4H), 1.42 (s, 6H), 1.39 – 1.19 (m, 16H). 13C NMR (101 MHz, CDCl3) δ 174.7, 
99.8, 98.8, 77.4, 74.6, 71.0, 65.3, 63.2, 62.2, 55.1, 54.1, 36.5, 29.1, 29.0, 28.9, 28.8, 28.7, 28.2, 
25.5, 19.1, 19.0. 
 
           Compound 18 (46 mg, 96%); white solid; mp 43.0-45.0 °C. 
1
H NMR (400 MHz, CDCl3) 
δ 5.81 (d, J = 9.5, 1H), 5.08 (t, J = 10.0, 1H), 4.68 (d, J = 3.5, 1H), 4.51 (dd, J = 12.2, 4.0, 1H), 
4.27 (d, J = 13.4, 1H), 3.78 (d, J = 9.7, 1H), 3.58 (t, J = 9.6, 1H), 3.39 (s, 3H), 2.48 (t, J = 7.3, 
1H), 2.40 – 2.18 (m, 3H), 1.90 – 1.73 (m, 2H), 1.57 – 1.45 (m, 2H), 1.44 – 1.17 (m, 12H), 0.87 
(t, J = 6.7, 3H).
13
C NMR (101 MHz, CDCl3): δ 172.2, 98.5, 78.2, 75.7, 73.6, 70.0, 68.5, 66.3, 
139 
 
65.0, 62.9, 55.3, 51.5, 35.0, 31.8, 29.1, 29.0, 28.8, 28.3, 23.9, 23.3, 22.6, 20.9, 20.8, 19.1, 18.6, 
14.1. 
 
 
             Compound  19 (46 mg, 95%); white solid; mp 51.0-52.0 °C. 
1
H NMR (400 MHz, 
CDCl3) δ 6.07 (d, J = 6.9, 1H), 4.67 (s, 1H), 4.03 (d, J = 25.8, 1H), 3.85 (s, 1H), 3.72 – 3.55  (m, 
2H), 3.38 (s, 3H), 2.23 (t, J = 6.9, 6H), 1.56 – 1.45 (m, 4H), 1.42 – 1.07 (m, 20H), 0.87 (t, J = 
6.7, 6H).
13
C NMR (101 MHz, CDCl3) δ 175.4, 135.4, 98.5, 77.6, 77.4, 75.6, 73.9, 71.3, 71.2, 
65.3, 65.2, 61.9, 55.2, 53.7, 36.5, 31.9, 29.6, 29.5, 29.3, 29.1, 29.1, 28.9, 28.8, 28.7, 28.4, 28.3, 
25.5, 22.7, 19.2, 14.1. 
 
           Compound 20 (43 mg, 95%); white solid; mp 44.0-46.0 °C. 
 1
H NMR (400 MHz, CDCl3) 
δ 6.65 – 6.50 (m, 2H), 4.60 – 4.53 (m, 6H), 3.57 – 3.31 (m, 6H), 3.25 (s, 6H), 2.28 – 2.05 (m, 
6H), 1.57 – 1.33 (m, 6H), 1.32 – 1.06 (m, 20H). 13C NMR (101 MHz, CDCl3) δ 176.5, 175.0, 
127.5, 114.4, 98.2, 77.3, 77.2, 71.9, 71.5, 70.6, 65.0, 61.3, 54.8, 53.4, 36.1, 33.8, 29.4, 28.9, 28.8, 
28.7, 28.6, 28.5, 28.4, 28.0, 25.4, 24.6, 18.9. 
 
           Compound 21 (39 mg, 95%); light blue solid; mp 49.5-51.0 °C . 
1
H NMR (400 MHz, 
CDCl3) δ 4.55 (d, J = 2.7, 2H), 4.50 – 4.42 (m, 1H), 3.81 – 3.39 (m, 2H), 3.35 – 3.28 (m, 1H), 
3.26 (s, 3H), 3.12 – 2.90 (m, 1H), 2.14 (t, J = 6.9, 7H), 1.48 – 1.09 (m, 15H), 0.79 (t, J = 6.8, 
5H).
13
C NMR (101 MHz, CDCl3) δ 159.4, 99.0, 98.9, 77.4, 77.2, 73.5, 73.2, 71.3, 70.6, 70.4, 
68.9, 66.9, 66.8, 65.1, 65.0, 61.2, 54.9, 54.0, 53.8, 40.0, 32.0, 30.8, 30.0, 29.8, 29.5, 29.0, 28.8, 
28.5, 28.4, 28.3, 28.2, 28.1, 27.8, 26.6, 23.2, 21.9, 18.9, 18.1, 13.6. 
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             Compound 22 (44 mg, 95%); light blue solid; mp 52.0-53.0 °C. 
 1
H NMR (400 MHz, 
CDCl3) δ 4.58 (t, J = 4.0, 1H), 3.72 (d, J = 2.1, 2H), 3.67 – 3.57 (m, 1H), 3.53 – 3.38 (m, 2H), 
3.28 (s, 3H), 3.11 – 2.92 (m, 1H), 2.15 (t, J = 7.0, 6H), 1.50 – 1.10 (m, 27H), 0.79 (t, J = 6.8, 
3H).
13
C NMR (101 MHz, CDCl3) δ 159.5, 99.0, 98.9, 77.4, 77.2, 73.4, 73.1, 71.4,  70.6, 68.9, 
66.8, 65.1, 65.0, 61.4, 54.9, 54.2, 40.1, 31.7, 29.8, 29.4, 29.3, 29.1, 29.0, 28.9, 28.7, 28.6, 28.2, 
28.1, 26.7, 22.5, 19.0, 18.9, 13.8. 
 
             Compound 11: N-acetal-methyl-α-D-glucosamine (5g, 21 mmol) was mixed with 
compound 24 (27 mmol) which was made in situ and p-toluenesulfonic acid (0.4g, 2 mmol) in 30 
mL DMF. The reaction mixture was stirred at 60°C in an oil bath for 12 hours and the reaction 
went completion. Solvent DMF was removed. The crude was mixed with KOH (20 g, 0.36 mol) 
and refluxed in 100 mL ethanol for 36 hours. Solvent was removed and reaction mixture was 
diluted with water and extracted with DCM 3x100 mL. The combined DCM was dried over 
sodium sulfate and purified by flash chromatography using hexane ethyl acetate gradient solvent 
system. The product was obtained as light yellow solid with a yield of 83%. 
1
H NMR (400 MHz, 
CDCl3) δ 7.07 – 6.99 (m, 3H), 6.88 – 6.81 (m, 1H), 5.49 (s, 1H), 4.68 (d, J = 3.5, 1H), 4.26 (dd, J 
= 9.8, 4.5, 1H), 3.90 (s, 3H), 3.87 (s, 3H), 3.84 – 3.77 (m, 2H), 3.77 – 3.69 (m, 1H), 3.45 (t, J = 
9.2, 1H), 3.41 (s, 3H), 2.79 (d, J = 6.8, 1H). 
13
C NMR (101 MHz, CDCl3) δ 149.7, 149.1, 130.0, 
119.1, 110.7, 109.1, 102.0, 101.3, 82.0, 71.8, 69.1, 62.5, 56.7, 55.9, 55.8, 55.4. 
 
General procedure for ester synthesis of compound 11 
              Compound 12 (85 mg, 0.25 mmol) was dissolved in 2mL anhydrous THF and pyridine ( 
0.1 mL, 1.3 mmol). Acyl chloride (0.33 mmol) was added to the mixture while it was cool in ice 
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bath. The resulting mixture was stirred at room temperature for 8 hour and reaction was 
complete. The reaction mixture was diluted with water and extracted with DCM 3x10 mL. The 
combined DCM was dried over sodium sulfate and purified by flash chromatography.  
 
            Compound 26A (11 mg, 7%); colorless liquid. 
1
H NMR (400 MHz, CDCl3) δ 8.93 (d, J = 
8.5, 1H), 8.66 (d, J = 8.6, 1H), 8.30 (d, J = 7.3, 1H), 8.00 (dd, J = 7.6, 4.6, 2H), 7.92 (d, J = 8.2, 
1H), 7.82 (dd, J = 19.6, 8.2, 2H), 7.65 – 7.31 (m, 6H), 7.03 (d, J = 7.1, 2H), 6.82 (d, J = 8.8, 1H), 
6.23 (t, J = 9.9, 1H), 5.59 (s, 1H), 5.45 (dd, J = 10.0, 3.6, 1H), 5.29 (t, J = 3.5, 1H), 4.42 (dd, J = 
10.3, 4.8, 1H), 4.16 (td, J = 9.9, 4.9, 1H), 3.97 (t, J = 9.6, 1H), 3.92 – 3.86 (m, 1H), 3.85 (s, 3H), 
3.78 (s, 3H), 3.50 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 166.7, 166.6, 149.4, 148.7, 134.1, 
133.8, 133.6, 133.1, 131.5, 131.4, 131.0, 129.7, 129.3, 128.6, 128.4, 128.0, 127.5, 127.4, 126.2, 
126.1, 125.6, 125.4, 124.6, 124.4, 118.7, 110.6, 109.0, 101.5, 98.1, 79.5, 72.2, 69.7, 68.9, 62.6, 
55.9, 55.7, 55.6. 
 
             Compound 26B (102 mg, 83%);
 
colorless liquid. 
1
H NMR (400 MHz, CDCl3) δ 8.92 (d, 
J = 8.6, 1H), 8.26 (d, J = 7.3, 1H), 8.05 (d, J = 8.2, 1H), 7.89 (d, J = 8.1, 1H), 7.67 – 7.58 (m, 
1H), 7.58 – 7.48 (m, 2H), 7.06 (dd, J = 6.0, 1.8, 2H), 6.91 – 6.83 (m, 1H), 5.56 (s, 1H), 5.21 (d, J 
= 3.8, 1H), 5.15 (dd, J = 9.6, 3.8, 1H), 4.42 (t, J = 9.4, 1H), 4.35 (dd, J = 10.2, 4.8, 1H), 4.02 – 
3.93 (m, 1H), 3.93 (s, 3H), 3.88 (s, 3H), 3.82 (t, J = 10.3, 1H), 3.67 (t, J = 9.4, 1H), 3.46 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 167.2, 149.8, 149.0, 133.8, 131.3, 130.8, 129.7, 128.6, 127.9, 
126.5, 126.3, 125.7, 124.5, 119.1, 110.7, 109.1, 102.2, 97.8, 81.5, 74.2, 68.9, 68.9, 62.1, 56.0, 
55.9, 55.6. 
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              Compound 27A (34 mg, 25%); white solid; mp 79.0-80.0 °C. 
1
H NMR (400 MHz, 
CDCl3) δ 7.99 (dd, J = 10.6, 4.0, 4H), 7.56 – 7.43 (m, 2H), 7.37 (dd, J = 16.4, 8.3, 4H), 6.97 (d, J 
= 7.0, 2H), 6.80 (d, J = 8.7, 1H), 6.05 (t, J = 9.8, 1H), 5.52 (s, 1H), 5.26 (dd, J = 9.9, 3.7, 1H), 
5.18 (d, J = 3.6, 1H), 4.37 (dd, J = 10.3, 4.8, 1H), 4.17 – 4.03 (m, 2H), 3.92 – 3.85 (m, 1H), 3.84 
(s, 3H), 3.81 (s, 3H), 3.44 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 166.0, 165.6, 149.4, 148.7, 
133.4, 133.0, 129.9, 129.7, 129.0, 128.4, 128.3, 118.7, 110.6, 109.0, 101.5, 97.8, 79.4, 75.5, 72.4, 
69.6, 68.9, 62.5, 55.9, 55.7, 55.5. 
 
              Compound 27B (73 mg, 66%); white solid; mp 83.5-84.5 °C.
 1
H NMR (400 MHz, 
CDCl3) δ 8.10 (d, J = 8.2, 2H), 7.58 (dd, J = 10.7, 4.1, 1H), 7.46 (t, J = 7.7, 2H), 7.05 (d, J = 6.4, 
2H), 6.86 (d, J = 8.7, 1H), 5.54 (s, 1H), 5.08 (d, J = 3.7, 1H), 5.04 (dd, J = 9.5, 3.8, 1H), 4.41 – 
4.28 (m, 1H), 4.16 – 4.02 (m, 1H), 3.91 (s, 3H), 3.88 (s, 3H), 3.79 (t, J = 10.3, 1H), 3.63 (t, J = 
9.4, 1H), 3.40 (s, 3H).
 13
C NMR (101 MHz, CDCl3) δ 166.2, 149.8, 148.9, 133.4, 129.9, 129.7, 
129.5, 128.4, 119.1, 110.7, 109.1, 102.1, 97.8, 81.5, 74.1, 68.9, 68.8, 62.0, 56.0, 55.9, 55.5. 
 
            For compound 28: 6-heptynoic acid (0.1 mL, 0.8 mmol) was mixed with 2 mL DCM and 
cooled in ice bath. 0.1 mL oxalyl chloride (0.08 mL, 1 mmol) was added to mixture slowly and 
followed by 1 drop anhydrous DMF. The mixture was stirred at room temperature for 2 hours at 
which time the reaction was complete. The solvent was removed under nitrogen and product was 
used immediately following the general procedure of amide synthesis.  
 
           Compound 28A (18 mg, 15%); colorless liquid. 
1
H NMR (400 MHz, CDCl3) δ 7.02 – 
6.94 (m, 2H), 6.83 (d, J = 8.2, 1H), 5.60 (t, J = 9.8, 1H), 5.46 (s, 1H), 4.95 (d, J = 3.6, 1H), 4.90 
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(dd, J = 9.9, 3.7, 1H), 4.29 (dd, J = 10.3, 4.8, 1H), 3.99 – 3.90 (m, 2H), 3.89 (s, 3H), 3.87 (s, 
3H), 3.76 (t, J = 10.3, 1H), 3.63 (t, J = 9.6, 1H), 3.41 (s, 3H), 2.45 – 2.28 (m, 7H), 2.26 – 2.16 
(m, 3H), 2.11 (td, J = 7.0, 2.5, 1H), 1.95 (dd, J = 4.8, 2.6, 1H), 1.91 (t, J = 2.6, 1H), 1.83 – 1.38 
(m, 5H).
 13
C NMR (101 MHz, CDCl3) δ 173.0, 172.3, 149.8, 149.0, 129.9, 119.1, 110.9, 109.3, 
101.8, 97.9, 79.5, 77.6, 77.2, 76.9, 71.7, 69.0, 68.9, 68.8, 62.5, 56.1, 56.0, 55.6, 33.9, 33.8, 27.9, 
27.8, 24.3, 24.2, 18.3, 18.2. 
 
 
           Compound  28B (74 mg, 75%); colorless liquid. 
1
H NMR (400 MHz, CDCl3) δ 7.10 – 
6.98 (m, 2H), 6.88 – 6.83 (m, 1H), 5.50 (s, 1H), 4.96 (d, J = 3.7, 1H), 4.80 (dd, J = 9.7, 3.8, 1H), 
4.29 (dd, J = 10.0, 4.7, 1H), 4.17 (dd, J = 16.7, 7.2, 1H), 3.90 (s, 3H), 3.87 (s, 3H), 3.75 (t, J = 
8.8, 1H), 3.58 – 3.52 (m, 1H), 3.40 (s, 3H), 2.45 (t, J = 7.3, 1H), 2.22 (td, J = 7.0, 2.6, 2H), 1.95 
(t, J = 2.6, 1H), 1.84 – 1.71 (m, 2H), 1.64 – 1.54 (m, 3H). 13C NMR (101 MHz, CDCl3) δ 173.1, 
149.8, 148.9, 129.7, 119.1, 110.7, 109.1, 102.1, 97.6, 81.4, 73.5, 68.9, 68.7, 68.6, 62.0, 55.9, 
55.9, 55.4, 33.6, 27.6, 24.0, 18.1. 
 
             Compound 29A (32 mg, 23%); colorless liquid. 
1
H NMR (400 MHz, CDCl3) δ 7.04 – 
6.94 (m, 2H), 6.83 (d, J = 8.2, 1H), 5.60 (t, J = 9.8, 1H), 5.45 (s, 1H), 4.91 (dt, J = 9.8, 3.7, 2H), 
4.29 (dd, J = 10.2, 4.9, 1H), 4.00 – 3.90 (m, 1H), 3.88 (s, 3H), 3.87 (s, 3H), 3.76 (t, J = 10.3, 
1H), 3.62 (t, J = 9.6, 1H), 3.40 (s, 3H), 2.41 – 2.19 (m, 4H), 1.71 – 1.47 (m, 6H), 1.38 – 1.11 (m, 
10H), 0.85 (dt, J = 21.9, 6.4, 6H). 
13
C NMR (101 MHz, CDCl3) δ 173.3, 172.5, 149.5, 148.8, 
129.7, 118.8, 110.6, 109.1, 101.5, 97.7, 79.3, 71.4, 68.8, 68.6, 62.3, 55.9, 55.8, 55.4, 34.3, 34.1, 
31.5, 31.4, 28.7, 28.6, 25.1, 24.9, 22.5, 22.4, 14.1, 14.0. 
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             Compound 29B (67 mg, 59%); colorless liquid.
 1
H NMR (400 MHz, CDCl3) δ 7.07 – 
7.01 (m, 2H), 6.88 – 6.83 (m, 1H), 5.51 (s, 1H), 4.96 (d, J = 3.7, 1H), 4.80 (dd, J = 9.7, 3.8, 1H), 
4.29 (dd, J = 10.0, 4.7, 1H), 4.19 (t, J = 9.5, 1H), 3.91 (s, 3H), 3.88 (s, 3H), 3.86 – 3.81 (m, 1H), 
3.75 (t, J = 10.2, 1H), 3.56 (t, J = 9.4, 1H), 3.40 (s, 3H), 2.41 (t, J = 7.5, 3H), 1.71 – 1.53 (m, 
4H), 1.35 – 1.24 (m, 3H), 0.88 (t, J = 6.7, 3H). 13C NMR (101 MHz, CDCl3) δ 173.6, 149.8, 
148.9, 129.7, 119.1, 110.7, 109.1, 102.1, 97.6, 81.4, 73.4, 68.9, 68.7, 62.0, 56.0, 55.9, 55.4, 34.1, 
31.4, 28.7, 24.9, 22.5, 14.0. 
 
             Compound 30A (20 mg, 15%); white solid; mp 56.0-58.0 °C. 
 1
H NMR (400 MHz, 
CDCl3) δ 7.03 – 6.95 (m, 2H), 6.83 (d, J = 8.2, 1H), 5.60 (t, J = 9.8, 1H), 5.46 (s, 1H), 4.94 (d, J 
= 3.7, 1H), 4.90 (dd, J = 9.8, 3.7, 1H), 4.29 (dd, J = 10.3, 4.8, 1H), 3.99 – 3.90 (m, 1H), 3.88 (s, 
3H), 3.87 (s, 3H), 3.76 (t, J = 10.3, 1H), 3.63 (t, J = 9.6, 1H), 3.41 (s, 3H), 2.41 – 2.20 (m, 3H), 
1.66 – 1.51 (m, 6H), 1.36 – 1.16 (m, 7H), 0.85 (dt, J = 11.2, 6.9, 6H). 13C NMR (101 MHz, 
CDCl3) δ 173.3, 172.5, 149.4, 148.7, 129.8, 118.8, 110.6, 109.1, 101.5, 97.7, 79.3, 71.4, 68.8, 
68.6, 62.3, 55.9, 55.8, 55.4, 34.3, 34.1, 31.2, 31.1, 24.8, 24.6, 22.3, 22.2, 13.9, 13.8. 
 
 
 
              Compound 30B (82 mg, 75%); white solid; mp 47.0-49.0 °C. 
1
H NMR (400 MHz, 
CDCl3) δ 7.06 – 7.01 (m, 2H), 6.88 – 6.83 (m, 1H), 5.51 (s, 1H), 4.96 (d, J = 3.7, 1H), 4.80 (dd, J 
= 9.7, 3.8, 1H), 4.29 (dd, J = 10.0, 4.6, 1H), 4.19 (td, J = 9.5, 2.3, 1H), 3.91 (s, 3H), 3.88 (s, 3H), 
3.85 – 3.81 (m, 1H), 3.75 (t, J = 10.2, 1H), 3.55 (t, J = 6.7, 1H), 3.40 (s, 3H), 2.41 (t, J = 6.3, 
3H), 1.66 (dt, J = 14.4, 7.3, 2H), 1.40 – 1.28 (m, 3H), 0.90 (t, J = 6.6, 3H). 13C NMR (101 MHz, 
CDCl3) δ 173.6, 149.8, 148.9, 129.7, 119.1, 110.7, 109.1, 102.1, 97.6, 81.4, 73.4, 68.9, 68.7, 
62.0, 56.0, 55.9, 55.4, 34.1, 31.1, 24.6, 22.3, 13.9. 
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General procedure for synthesis of amides of compound 12 
             Compound 12 (100 mg, 0.3 mmol) was mixed with pyridine (0.12 mL, 1.5 mmol) in 
2mL anhydrous THF. Acyl chloride (0.36 mmol) was added to the mixture while it was cooled in 
ice. The mixture was stirred at room temperature for 8 hours and reaction was complete. The 
reaction mixture was diluted with water and extracted with DCM 3x10 mL. The combined DCM 
was dried over sodium sulfate and purified by flash chromatography.   
 
            Compound 31 (164 mg, 78%);
 
white solid; mp 74.5-76.0 °C. 
1
H NMR (400 MHz, 
CDCl3) δ 7.05 – 7.01 (m, 2H),  6.86 – 6.81 (m, 1H), 5.84 (d, J = 8.6, 1H), 5.52 (s, 1H), 4.71 (d, J 
= 3.8, 1H), 4.31 – 4.18 (m, 2H), 3.89 (s, 3H), 3.86 (s, 3H), 3.82 – 3.72 (m, 2H), 3.57 (t, J = 9.0, 
1H), 3.41 (s, 3H), 3.15 (d, J = 2.6, 1H), 2.25 (t, J = 7.6, 2H), 1.72 – 1.54 (m, 3H), 1.38 – 1.27 (m, 
3H), 0.89 (t, J = 6.7, 3H).
 13
C NMR (101 MHz, CDCl3) δ 175.0, 149.9, 148.9, 129.9, 119.1, 
110.7, 109.2, 102.0, 98.8, 82.1, 75.6, 71.0, 68.8, 62.3, 55.9, 55.8, 55.3, 54.0, 36.6, 31.3, 25.3, 
22.3, 13.9. 
  
           Compound 32 (94mg, 72%); white solid; mp 69.0-70.0 °C .
 1
H NMR (400 MHz, CDCl3) δ 
7.05 – 7.01 (m, 2H), 6.88 – 6.80 (m, 1H), 5.85 (d, J = 8.5, 1H), 5.51 (s, 1H), 4.71 (d, J = 3.8, 
1H), 4.29 – 4.18 (m, 2H), 3.89 (s, 3H), 3.86 (s, 3H), 3.82 – 3.71 (m, 2H), 3.60 – 3.51 (m, 1H), 
3.40 (s, 3H), 3.18 (d, J = 3.1, 1H), 2.24 (t, J = 7.5, 2H), 1.71 – 1.56 (m, 3H), 1.38 – 1.22 (m, 5H), 
0.87 (t, J = 6.5, 3H). 
13
C NMR (101 MHz, CDCl3) δ 174.8, 149.6, 148.9, 129.8, 119.1, 110.7, 
109.2, 102.0, 98.8, 82.1, 75.6, 70.9, 68.8, 62.3, 55.9, 55.8, 55.3, 54.0, 36.6, 31.5, 28.8, 25.5, 22.5, 
14.0.  
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           Compound 33 (114 mg, 83%); white solid; mp 81.0-83.0 °C. 
1
H NMR (400 MHz, CDCl3) 
δ 7.05 – 7.01 (m, 2H), 6.86 – 6.81 (m, 1H), 5.85 (d, J = 8.6, 1H), 5.51 (s, 1H), 4.71 (d, J = 3.8, 
1H), 4.31 – 4.17 (m, 2H), 3.89 (s, 3H), 3.86 (s, 3H), 3.81 – 3.71 (m, 2H), 3.60 – 3.51 (m, 1H), 
3.40 (s, 3H), 3.20 (d, J = 3.3, 1H), 2.24 (t, J = 7.5, 2H), 1.72 – 1.58 (m, 5H), 1.37 – 1.19 (m, 5H), 
0.87 (t, J = 6.6, 3H). 
13
C NMR (101 MHz, CDCl3) δ 174.8, 149.7, 148.9, 129.8, 119.1, 110.7, 
109.2, 102.0, 98.8, 82.1, 70.9, 68.8, 62.3, 55.9, 55.8, 55.3, 54.0, 36.6, 31.6, 29.1, 28.9, 25.6, 22.6, 
14.0. 
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